WO2020229711A1 - Micro- and nanoemulsions of hemp oil cannabinoids - Google Patents

Micro- and nanoemulsions of hemp oil cannabinoids Download PDF

Info

Publication number
WO2020229711A1
WO2020229711A1 PCT/ES2019/070769 ES2019070769W WO2020229711A1 WO 2020229711 A1 WO2020229711 A1 WO 2020229711A1 ES 2019070769 W ES2019070769 W ES 2019070769W WO 2020229711 A1 WO2020229711 A1 WO 2020229711A1
Authority
WO
WIPO (PCT)
Prior art keywords
cyclodextrin
micro
oil
surfactant
nanoemulsion
Prior art date
Application number
PCT/ES2019/070769
Other languages
Spanish (es)
French (fr)
Inventor
Jaime Antonio FABREGAS CASAL
Original Assignee
Elixinol, B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elixinol, B.V. filed Critical Elixinol, B.V.
Publication of WO2020229711A1 publication Critical patent/WO2020229711A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00Whey; Whey preparations
    • A23C21/08Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1528Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/003Compositions other than spreads
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053Compositions other than spreads
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/02Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by the production or working-up
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11CFATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/003Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Definitions

  • the invention refers to the procedure for obtaining a micro and nanoemulsion of cannabinoids containing hemp oil that transforms the triglycerides of the oil into mono and diglycerides which have emulsifying capacity.
  • This procedure allows the use of fewer surfactants than traditional systems.
  • the micro and nanoemulsion comprising cannabinoids mainly contains cannabidiol (CBD), as well as the beverage, food, supplement or supplement, and cosmetic or pharmaceutical compositions comprising said micro and nanoemulsions.
  • CBD cannabidiol
  • the obtaining procedure is biochemical and chemical, and the application is framed in the sector of food, supplements and food supplements, cosmetics and medicine.
  • cannabinoids The global demand for cannabinoids is increasing. Most of the naturally occurring cannabinoids come from! hemp oil. Hemp refers to three species: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Humans have cultivated and used cannabis for thousands of years, from the ancient Romans and Greeks to the Middle East, Africa, China, and India. There are more than 100 cannabinoids from hemp. The best known are the non-psychoactive cannabidiol (CBD) and the psychoactive tetrahydrocannabinol (THC).
  • CBD non-psychoactive cannabidiol
  • THC psychoactive tetrahydrocannabinol
  • CBD cannabidiol
  • a first step in concentrating the cannabinoids in hemp is to extract the oil from the leaves or trichomes.
  • Different methodologies are used, one of them is pressure treatment and, subsequently, they are concentrated with little polar solvents or with supercritical CO 2 .
  • Cannabinoids are more soluble in nonpolar liquids. This feature makes it easy to use solvents effective as hexane and methanol, among others, to dissolve them, since polar dissolves its polar.
  • a traditional extraction is to use a solvent such as hexane that extracts the cannabinoids, but also other molecules of similar polarity and, later, remove the hexane with a rotary evaporator.
  • the final product is an oil that is generally solid at room temperature due to the presence of high molecular mass lipids, generally waxes. Some of these lipids can be separated from the rest of the oil through freeze-thaw cycles, producing an oil that is liquid at room temperature.
  • This methodology makes it possible to obtain an oil with a concentration from 2% to 70% of cannabinoids, preferably from 20% to 65%, depending on the concentration or partial purification process.
  • chromatographic methods can be used to concentrate the cannabinoids, separating them from the rest of the components present in the oil. Chromatographic methods make it possible to obtain cannabinoids with a purity level greater than 95%, even though they are time consuming and costly.
  • the cannabinoids contained in hemp oil, specifically cannabidiol (CBD) are not very polar and are insoluble in water. This characteristic makes intestinal absorption difficult.
  • cannabinoids To more effectively use cannabinoids in food, beverages, supplements or food supplements, cosmetics or medicine, it is necessary to microcapsulate, nanocapsulate or make micro and nanoemulsions of cannabinoids, among other methodologies and, always with a size smaller than 55 micrometers so that they can be absorbed by the intestinal villi. To produce micro and nanoemulsions of the cannabinoids contained in hemp oil, it is necessary to micro and nanoemulsify the fraction of the oil that mainly contains the triglycerides of fatty acids.
  • a high concentration of non-ionic surfactants is needed generally in an oil / surfactant ratio of 1: 9 for the micro and nanoemulsion to be translucent or transparent when dissolved in water, since they are not only micro and nanoemulsified cannabinoids if not also, it is necessary micro and nanoemulsify triglycerides.
  • fatty acids are esterified with glycerol to form triglycerides. They can also get cannabinoids, usually between 20 and 50%. These esterified fatty acids from hemp oil are low polar, and do not dissolve in water. To micro and nanoemulsify them together with cannabinoids, it is necessary to use high concentrations of surfactants and cosurfactants.
  • lipids with a higher molecular mass need a higher concentration of surfactants to produce micro and nanoemulsions than do lipids with a lower molecular mass.
  • hemp oil lipolysis occurs when lipases are mixed with the oil.
  • a process of glycerolysis of oil or fat is described using a lipase in the presence of water, but it does not use a mixture of the oil. with the surfactant and the ipase dissolved in water, as performed in the present invention.
  • the surfactant increases the contact surface of the lipase with the oil and improves the efficiency of glycerolysis. Also, it does not claim its use for hemp oil.
  • Nanoemulsion compositions and methods of use thereof uses a nanoemulsion composition comprising a protein or protein fragment complex and wherein the nanoemulsion contains hemp oil, and at least one Phospholipid selected from a group consisting of phosphatidylserine with a concentration equal to or greater than 40% in addition, it uses phosphatidylserine because it plays a critical role in the maintenance of optimal mental performance and in addition, the preferred formulation is the inclusion of phospholipids rich in phosphatidylserine in the oil phase after emulsification Hemp oil is also used in the present invention, but unlike the above mentioned patent, it uses phosphatidylserine as an emulsifier and also at a concentration lower than 40%.
  • the first aspect of the present invention is a process for obtaining a micro and nanoemulsion of a size smaller than 55 mm from hemp oil comprising cannabinoids, characterized in that it comprises the following steps: i. treat a hemp oil that contains cannabinoids,
  • At least one lipase enzyme that transforms the lipids with the highest molecular mass to di- and monoglycerides of fatty acids, fatty acids and glycerol, for a time of between 1 minute up to 72 hours of treatment, and at a temperature between 2 ° C and 60 ° C;
  • step (ii). adding at least one antioxidant to the product obtained in step (i); and iii. provide energy to the product obtained in stage (ii), by means of a method selected from stirring at a stirring speed of between 100 rpm and 30,000 rpm, where the action time is between 10 seconds and 1 hour, or by ultrasound, at a power between 20 and 3,000 watts and at a frequency between 10 and 30 kHz for a sonication time of between 5 seconds and 10 minutes.
  • emulsion is understood to be a colloidal dispersion of two immiscible liquids, such as oil and water, in the form of drops. If the oil droplets are finely dispersed in water, then it is an oil-in-water emulsion. When the water droplets are finely dispersed in oil, it is a water-in-oil emulsion.
  • micro and nanoemulsions is understood to refer to the production of a mixture of micro and nanoemulsions of hemp oil containing cannabinoids with the same procedure. They differ from an emulsion in that they are thermodynamically stable in the long term without apparent flocculation or coalescence, whereas an emulsion is only kinetically stable, that is, the rate at which the emulsified phase separates from water is slow.
  • microemulsions are considered to have micrometer diameters and can be transparent or translucent. Nanoemulsions have nanometer diameters and are transparent.
  • hemp oil is understood to refer to oil extracted from hemp, mainly from trichomes and preferably without waxes, where cannabinoids can be present from 5% to 50%.
  • hemp oil may contain 20% cannabidiol.
  • hemp or industrial hemp! is the name given to the varieties of the Cannabis plant: Cannabis sativa, Cannabis indica and Cannabis ruderalis. The varieties of Cannabis intended for! Is called “industrial hemp”. industrial and food use.
  • Hemp contains cannabinoids among many other components.
  • Cannabidiol, also known as CBD is one of the two most important cannabinoid components of the plant, which is found in variable proportions depending on the strain.
  • cannabinoids are understood to be highly lipophilic molecules with very low levels of aqueous solubility (2-15 mm / mL). They are susceptible to degradation, especially in solution, through the action of light and temperature, as well as through autoxidation. It is found in the Cannabis species. There are more than 100 cannabinoids from hemp. The best known are the non-psychoactive cannabidiol (CBD) and the psychoactive tetrahydrocannabinol (THC). They have a wide range of applications for human and animal health.
  • CBD non-psychoactive cannabidiol
  • THC psychoactive tetrahydrocannabinol
  • antioxidants are understood as the recognized fat-soluble natural antioxidants (tocopherols, tocotrienies, beta-carotene and coenzyme Q10).
  • Hemp oil mainly contains triacylglycerides of fatty acids among other molecules in percentages that can vary, depending on the production method, from 90% to 50%.
  • the triglycerides of the fatty acids in the oil of hemp oil have a higher molecular mass than the diglycerides and these more than the monoglycerides.
  • the di- and monoguerides have a certain emulsifying capacity.
  • Monoglycerides and diglycerides are commonly added to commercial food products in small amounts. They act as emulsifiers, helping to mix insoluble ingredients that would not otherwise mix. This characteristic helps to lower the concentration of surfactants to produce micro and nanoemulsions of hemp oil.
  • hemp oil contains cannabidiol among other cannabinoids and triglycerides, where both groups can be in different proportions depending on the extraction methodology.
  • the oil mixture of cannabinoids and triglycerides
  • the advantage provided by this procedure is the initial enzymatic treatment with a lipase to transform the triglycerides into mono and diglycerides that in turn have emulsifying capacity and for this reason it is only necessary to use a very low concentration of other emulsifiers.
  • the method refers to a process to produce micro and nanoemulsions of hemp oil containing cannabinoids whose iipids have been transformed into di- and monoglycerides of fatty acids or ethyl or methyl esters of fatty acids or a combination of both, to use less concentration of surfactants and cosurfactants so that cannabinoids can be dispersed in a water phase or in a solid food phase, and that they have a diameter less than 55 micrometers and that, in addition, translucent or transparent micro and nanoemulsions are produced in a phase of Water.
  • the enzymes of step i) are lipases, which produce lipolysis, of animal, microbial or plant origin, from 5 units of lipase per gram of oil to 12,000 units of lipase per gram of oil and they are in an amount of between 0.2 g to 100 g per 100 liters of oil.
  • Iipase enzymes can act, by definition, at the organic-aqueous interface, catalyzing the hydrolysis of the ester-carboxylate bonds and releasing fatty acids and organic alcohols.
  • the Iipases catalyze the hydrolysis of triacylglycerols to di- and monoglycerols, and to fatty acids and glycerol in a random manner, the intermediate products being mono- and diacylglycerols.
  • Lipases can be of animal origin (pancreatic, liver, and gastric), microbial (bacterial, fungal, and yeast), or plant, and vary in their catalytic properties. There are different types of lipases. Specific lipases: have glycerol esters as specific substrates. They catalyze the hydrolysis of triacylglycerols, as well as di- and monoacylglycerols. Non-specific lipases: they catalyze the complete hydrolysis of the triacylglycerols into fatty acids and glycerol in a random way, the intermediate products being mono- and diacylglycerols.
  • Lipases are produced and derived from porcine pancreas, human pancreas, polio adipose tissue, bovine milk, wheat germ. Lipases derived from microorganisms of the genera Rhizopus, Aspergillus, and Mucor, Phizopus delemar, Phizopus oryzae, Rhizopus japonicus, Rhizopus niveus, Aspergillus niger, Asperfillus oryzae, Pseudomonas espacia, Pseudomonas fiáruoresicatica, Candida antifaruoresica, Candida spolyk, fiáruorestica, Candida spolyk, fiáruorestica, Candida antifarica, Candida lipidia. Penicillium camemberti, Mucor javanicus and Mucor miehei.
  • Lipase activity is measured in U / mL. They act from 5 units of lipase per gram of oil to 12,000 units of lipase per gram of oil, preferably between 100 and 1,200 IU per gram, preferably from 100 U / g to 600 U / g and more preferably from 200 U / g to 400 U / g.
  • the activity of the lipase depends on the origin of the lipases. In other lipases, the activity range varies from 1,200 U / g to 1,800 U / g.
  • the ratio of porcine type II lipase (100 to 500 Units / mg) to oil may be 5-10 mg / mL, although in another embodiment, it uses 10 grams of oil with 20 mL of water and from 1.5 g to 6 g of lipase.
  • the actuation time preferably ranges from 10 minutes to 120 hours, more preferably 1 to 90 hours.
  • Lipases operate from room temperature to 20 ° C to 50 ° C, preferably between 35 ° C and 50 ° C and are preferably inactivated at 90 ° C.
  • the lipase is added from 0.2 g to 100 g per 100 liters, preferably from 5 g to 20 g per 100 liters, and from 1 minute to 72 hours of treatment, preferably from 1 hour to 24 hours. Temperature can vary from 2 ° C to 60 ° C, preferably from 25 ° C to 40 ° C. Lipases transform the higher molecular weight lipids of hemp oil containing cannabinoids into lower molecular weight products. Lipases do not transform cannabidiol.
  • the lipase enzymes of step (i) are combined with proteases, amylases or cellulases to decrease the molecular weights of the residual proteins, polysaccharides and cellulose to peptides or amino acids and monosaccharides.
  • step (i) are used in immobilized format.
  • step (i) it also comprises adding at least one surfactant in step (i) in an amount of between 1% and 25% by weight with respect to the initial hemp oil amount.
  • Immobilized lipases are heat resistant and have high durability over a wide range of concentrations. Many of the immobilized lipases and lipases are readily available as products on the market.
  • the amount of lipase used is preferably 0.1 to 30% by weight, particularly 1 to 15% by weight (200 to 100,000 units per gram of oil or fat) based on the raw materials for the reaction.
  • a metonolysis or ethanolysis is produced and it is carried out enzymatically with lipases without the presence of water or in low concentration.
  • non-ionic surfactant refers to different synonyms of a generally amphiphilic agent with a hydrophilic head and a hydrophobic tail with the same or different character. hydrophilic or lipophilic, which tends to decrease the surface tension between two phases and to be non-ionized in neutral solutions.
  • non-ionic surfactants are Tween 80, Tween 20, Span 80. It is known that lipids with a higher molecular mass need a higher concentration of surfactants to disperse them in micro and nanoemulsions in an aqueous phase.
  • high molecular volume oils such as soybean and sunflower oils
  • the lower molecular volume triglyceride, tributyrin (butyric + glycerol) produces a large region clear single phase
  • surfactants of additional step (ii ') are selected from the list consisting of lecithin, phosphatidylserine, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, and phosphatidic acid or their combinations, additionally they are added in combination with at least:
  • non-ionic surfactant selected from among Tween 20, Tween 40, Tween 80, Tween 80, Tween 21, Tween 85, Tween 65, Tween 81, Tween 61 and Tween 100;
  • Span 20 Span 40, Span 60, Span 85, and Span 85;
  • sulfactant that is selected from the list consisting of starches, milk caseinate, milk powder, soy protein, pea protein and whey protein; or
  • weight ratio of total surfactants and hemp oil ranges from 10: 1 to 1: 100.
  • it comprises adding at least one cosurfactant, where said cosurfactant is selected from the group ethanol, methanol, xylitol, sorbitol, glycerol, maititol or erythritol, or any of their combinations.
  • cosurfactant is selected from the group ethanol, methanol, xylitol, sorbitol, glycerol, maititol or erythritol, or any of their combinations.
  • cosurfactant is generally understood to be alcohols or amines within the C4 to C10 range that help the formation and stabilization of micro- and nanoemulsions.
  • FAME fatty acid ethyl or methyl esters
  • the methanolysis of a fatty compound is the result of three consecutive reactions: partial transesterification of the triglyceride (TG) to form the diglyceride (DG), partial transesterification of the DG to form the monoglyceride (MG), and partial transesterification of the MG to form the FAME and glycerol (G).
  • TG triglyceride
  • MG diglyceride
  • G FAME and glycerol
  • FAME glycerol
  • 0.5% to 1% KGH or NaOH are needed as catalyst, ethanol or methanol.
  • Fatty compounds must have an acid value less than 1 mg KOH / g.
  • the alcohol / oil ratio preferably ranges from 3: 1 to 6: 1.
  • the reaction time of 0.1 hours at a temperature of 60 ° C has a FAME production efficiency of 94%.
  • FAME can be used as solvents and help the dispersion of cannabinoids found in hemp oil and, in this way, a lower concentration of cosurfactants is needed, of surfactants such as iecithins or their derivatives, of biosurfactants, of surfactants natural, certified organic surfactants, and synthetic surfactants such as ios Tweens or Spans, and their combinations, for the production of micro and nanoemulsions of ios cannabinoids present in hemp oil.
  • surfactants such as iecithins or their derivatives
  • biosurfactants of surfactants natural, certified organic surfactants
  • synthetic surfactants such as ios Tweens or Spans
  • non-ionic, natural or ecological surfactants can be used than in current methodologies when using hemp oil processed according to the above methodologies.
  • a mixture of two phosphoipids such as the phosphatidiyserine / phosphatidylcholine mixture in a ratio from 1: 10 to 35:65, preferably 1: 5 in a concentration from 1% to 39%. and another non-phospholipid surfactant to produce micro and nano emmisions.
  • phosphatidiyserine / phosphatidiicholine and Tween 80 or phosphatidiyserine / phosphatidylcholine and modified starch or phosphatidiyserine / phosphatidylcholine and gum arabic.
  • Phosphatidiserine is a natural component of all biological membranes and is most concentrated in the brain.
  • the phosphoipids used can be produced synthetically or prepared from natural sources.
  • Lecithins, phosphatidyl choline and phosphatidiyserine are considered Generally Recognized as Safe (GRAS). Both are derived from lecithins of plant or animal origin and are suitable for performing emulsions of micrometric or nanometric range of vegetable and animal oils.
  • phosphatidylserine can be substituted for or combined with phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, and phosphatidic acid.
  • surfactants of natural origin such as phospholipids and cosurfactants such as glycerol are used in the present invention to reduce the use of non-ionic surfactants to produce said emulsions.
  • non-ionic surfactants are generally safe, consumers demand food, beverages, supplements or food supplements, cosmetics and medicine with low concentrations of non-ionic surfactants and, if possible, natural surfactants and better yet with an ecological name.
  • the desiccant is selected from among monophosphate, diphosphate, triphosphate, polyphosphate, citric
  • the final volume increases in the order of 10 times the initial volume, however, if the desiccant is selected from among monophosphate, diphosphate, triphosphate, polyphosphate, citric, citrates, ascorbic, ascorbate the volume increases less than double, facilitating the formation of the micro and nanoemulsion.
  • step (v) of dispersing the product obtained in step (iii) or (iv) in an aqueous phase;
  • clear or transparent is understood to refer to an aqueous solution containing the lipophilic compound in a water-containing solution that is free of visible particles of dispersed (non-dissolute) compound.
  • it further comprises adding at least one cyclodextrin in an amount in percentage by weight of between 5% and 400% with respect to the initial hemp oil, selected from a-Cyclodextrin, b -Cyclodextrin, y-Cyclodextrin, d-Cyclodextrin and derivatives such as 2-Hydroxypropyl- b-cyclodextrin, 2, Hydroxyethyl- b-iclodextrin, 2-Hydroxypropyl- y-cyclodextrin, 2-Hydroxypropyl-a-cyclodextrin, Methyl-b-cyclodextrin , Carboxymethyl-b-cyclodextrin sodium sai, 2-Carboxyethyl-b-iclodextrin, sodium salt, Acetii- b-iclodextrin, Succinyl-cyclo
  • the liquid or solid emulsion has the characteristic smell and taste of hemp.
  • the removal or suppression of taste and odor can provide an advantage over other procedures.
  • the characteristic hemp odor and taste of the emulsion can be removed or suppressed using cyclodextrins.
  • Cyclodextrins are ring-bound monosaccharides (cyclic oligosaccharides) of 5 or more ⁇ -D-glucopyranoside (cyclic glucose) units.
  • cyclodextrins are used in the pharmaceutical industry to increase the solubility of some drugs in water, they can also be used to trap volatile odor-related molecules and taste-related molecules.
  • a second aspect of the present invention is a micro and nanoemulsion obtained according to the procedure described above.
  • a third aspect of the present invention refers to a micro and nanoemulsion (henceforth the emulsion of the present invention) characterized in that it comprises
  • micro and nanoemulsions have a size smaller than 55 mm.
  • the enzyme is a lipase and is selected from lipases of animal, microbial or plant origin.
  • the emulsion of the present invention also comprises other enzymes selected from among proteases, amylases, cellulases and any combination of the above.
  • the cannabinoid is cannabidiol.
  • the emulsion of the present invention further comprises at least one surfactant, preferably selected from natural phosphatidic surfactant, surfactant of animal origin and any combination, and more preferably natural phosphatidic surfactant in combination with a non-ionic surfactant.
  • at least one surfactant preferably selected from natural phosphatidic surfactant, surfactant of animal origin and any combination, and more preferably natural phosphatidic surfactant in combination with a non-ionic surfactant.
  • the emulsion of the present invention further comprises at least one cosurfactant, preferably selected from ethanol, methanol, xylitol, sorbitol, glycerol, maltitol or erythritol, or their combinations.
  • cosurfactant preferably selected from ethanol, methanol, xylitol, sorbitol, glycerol, maltitol or erythritol, or their combinations.
  • the antioxidant is selected from tocopherols, alpha, beta, gamma or delta tocopherols, tocotrienols, alpha, beta, gamma or delta tocotrienols, astaxanthin, phospholipids, ubiquinol, ubiquinone, glutathione, and their combinations.
  • the emulsion of the present invention also comprises at least one emulsifying agent, preferably selected from maltodextrin, glucose, lactose, maititol, xylitol, erythrite, fructose, methyl cellulose, hydroxypropylmethylcellulose, microcrystalline cellulose, whey protein, protein milk, hemp protein, pea protein, soy protein, milk powder or their combinations.
  • at least one emulsifying agent preferably selected from maltodextrin, glucose, lactose, maititol, xylitol, erythrite, fructose, methyl cellulose, hydroxypropylmethylcellulose, microcrystalline cellulose, whey protein, protein milk, hemp protein, pea protein, soy protein, milk powder or their combinations.
  • the emulsion of the present invention also comprises at least one cyclodextrin in an amount in percentage by weight of between 5% and 400% with respect to the initial hemp oil, selected from a- Cyclodextrin, b- iclodextrin, y-Cyclodextrin, s- Cyclodextrin and derivatives such as 2- Hydroxypropyl b-iclodextrin, 2, Hydroxyethyl- b-iclodextrin, 2-Hydroxypropyl-y- cyclodextrin, 2-Hydroxypropyl-a-cyclodextrin, Methyl-b-iclodextrin Carboxymethii-b- cyclodextrin sodium sodium, 2-Carboxyethyl-b-iclodextrin, sodium salt, Acetyl-b-iclodextrin, Succinyl-b-iclodextrin, Succinyl-b-
  • the monoglyceride and diglyceride, the fatty acids and the glycerol are the product of the reaction of hemp oil with enzymes.
  • a fourth aspect of the present invention is a composition comprising the micro and nanoemulsion described according to the present invention.
  • said composition is a food, a beverage, a food supplement or supplement, a cosmetic composition or a pharmaceutical composition.
  • the beverage is selected from the group consisting of energy drink, drinking or mineral water, lemonade, tonic water, fruit water, fruit juice, milk, buttermilk, carbonated drink and soft drink. alcoholic.
  • the emulsified hemp oil is present in a formulation dispersed in water, for example, in a beverage at a concentration from 0.001% by weight to 10% by weight, preferably from 0.05% to 0.2 %.
  • composition of the formulation can be in any oral or dermal dosage format.
  • Oral liquid preparations include liquids, beverages, syrups, suspensions, gels, etc., suitable for whoever ingests them.
  • a water soluble formulation as described herein can be sprayed directly onto the skin.
  • the emulsified hemp oil is mixed with, maltodextrin, glucose, lactose, maltitol, xylitol, erythritol, fructose, methyl cellulose, hydroxypropylmefilcellulose, microcrystalline cellulose, whey protein, milk protein, protein of hemp, pea protein, soy protein, milk powder or in their combinations to obtain a dry powder.
  • the formulation dispersed in water is in a concentration of from 0.005% to 10%, preferably from 0.1% to 2%.
  • Example 1 micro and nanoemulsions.
  • Group A 100 g of hemp oil containing 30% cannabidiol.
  • Group B 400 IU / g of pancreatic or bacterial lipase dissolved in 20 mL of water and 5 g of Tween 80.
  • Group A and B are mixed with stirring for 24 hours and at a temperature of 30 ° C. Heat to 90 ° C to deactivate the enzymes
  • 0.1 mL of the liquid micro and nanoemulsions are dispersed in 100 mL of a beverage.
  • 250 of maltodextrin are mixed with 50 mL of the micro and nanoemulsions.
  • 0.8 g of the micro and nanoemulsion powder is mixed with 100 g of a food, drink, food supplement or supplement, cosmetic product or medicine.
  • Example 2 micro and nanoemulsions with previously transesterified hemp oil.
  • a methanolysis occurs through a standard transesterification with NaOH and methanol. Excess methanol is removed using a rotary evaporator.
  • liquid micro and nanoemulsions are dispersed in 100 mL of a cosmetic serum.
  • 0.8 g of the micro and nanoemulsion powder is mixed with 100 g of a food, drink, food supplement or supplement, cosmetic product or medicine.
  • Example 3 micro and nanoemulsions with natural surfactants.
  • liquid micro and nanoemulsions are dispersed in 100 mL of a cosmetic serum.
  • micro and nanoemulsion powder 250 of skimmed milk powder are added with 50 mL of the micro and nanoemulsions and 0.8 g of the micro and nanoemulsion powder are mixed with 100 g of a food, drink , food supplement or supplement, cosmetic product or medicine.
  • Example 4 micro and nanoemulsions
  • Group A 100 g of hemp oil when the amount of cannabidiol is less than 20%.
  • Group B 400 lil / g of pancreatic or bacterial lipase dissolved in 20 mL of water.
  • Group A and B are mixed with stirring for 24 hours and at a temperature of 30 ° C. Heat to 90 ° C to deactivate the enzymes
  • Liquid micro and nanoemulsions are obtained.
  • Example 5 Micro and direct nanoemulsions
  • hemp oil containing 30% cannabidiol 1,000 IU / g of bacterial lipase with 0.1% of water and 4% of the cosurfactant glycerol are added.
  • the pH is adjusted to 7 with NaOH.
  • the mixture is incubated at a temperature of 50 ° C for 14 hours and at 600 rpm.
  • the enzyme is subsequently deactivated at 90 ° C.
  • the emulsion is stirred at 3,000 rpm for 5 minutes.
  • 0.1 mL of the liquid micro and nanoemulsions are dispersed in 100 mL of a beverage.
  • a powder product of the liquid micro and nanoemulsions 250 of maltodextrin are mixed with 50 mL of the micro and nanoemulsions.
  • 0.8 g of powdered micro and nanoemulsion ias is mixed with 100 g of a food, drink, food supplement or supplement, cosmetic product or medicine.
  • Example 6 Eliminate or suppress the taste and odor of the emulsion
  • Example 2 To the product obtained in Example 1, an amount of 100 g of a-Cyclodextrin is added, to eliminate or suppress the smell and taste of the emulsion, to the 0.8 g of the micro and nanoemulsion powder and they are added to the 100 g of a food, drink, food supplement or supplement, cosmetic product or medicine.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

The invention relates to the method for obtaining a micro- and nano-emulsion of cannabinoids containing hemp oil which converts the oil triglycerides into monoglycerides and diglycerides with emulsification capacity. The method allows the use of a smaller amount of surfactants compared with traditional systems. The cannabinoid-containing micro- and nano-emulsion contains mainly cannabidiol (CBD), as do the beverage, food product, complement or supplement, and cosmetic or pharmaceutical compositions comprising said micro- and nano-emulsions. The method for obtaining these is biochemical and chemical, and the application relates to the fields of food science, food complements and supplements, cosmetics and medicine.

Description

Micro y nanoemulsi ones de los cannabinoides del aceite de cáñamo Micro and nanoemulsions of cannabinoids from hemp oil
DESCRIPCIÓN DESCRIPTION
La invención se refiere al procedimiento de obtención de una micro y nanoemulsión de ios cannabinoides que contiene el aceite de cáñamo que transforma los triglicéridos del aceite en mono y diglicéridos los cuales tienen capacidad emulsionante. Este procedimiento permite utilizar una menor cantidad de surfactantes que ios sistemas tradicionales. La micro y nanoemulsión que comprende cannabinoides, contiene principalmente cannabidiol (CBD), así como la bebida, alimento, complemento o suplemento, y composiciones cosméticas o farmacéuticas que comprenden dichas micro y nanoemulsiones. El procedimiento de obtención es bioquímico y químico, y la aplicación se encuadra en el sector de la alimentación, complementos y suplementos alimenticios, cosmética y medicina. The invention refers to the procedure for obtaining a micro and nanoemulsion of cannabinoids containing hemp oil that transforms the triglycerides of the oil into mono and diglycerides which have emulsifying capacity. This procedure allows the use of fewer surfactants than traditional systems. The micro and nanoemulsion comprising cannabinoids, mainly contains cannabidiol (CBD), as well as the beverage, food, supplement or supplement, and cosmetic or pharmaceutical compositions comprising said micro and nanoemulsions. The obtaining procedure is biochemical and chemical, and the application is framed in the sector of food, supplements and food supplements, cosmetics and medicine.
ANTECEDENTES DE LA INVENCIÓN BACKGROUND OF THE INVENTION
La demanda mundial de cannabinoides está aumentando. La mayor parte de ios cannabinoides de origen natural provienen de! aceite de cáñamo. El cáñamo se refiere a tres especies: Cannabis sativa, Cannabis indica y Cannabis ruderalis. Los seres humanos han cultivado y consumido cannabis durante miles de años, desde los antiguos romanos y ios griegos hasta Oriente Medio, África, China e India. Existen más de 100 cannabinoides procedentes del cáñamo. Los más conocidos son el cannabidiol no psicoactivo (CBD) y el psicoactivo tetrahidrocannabinol (THC). The global demand for cannabinoids is increasing. Most of the naturally occurring cannabinoids come from! hemp oil. Hemp refers to three species: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Humans have cultivated and used cannabis for thousands of years, from the ancient Romans and Greeks to the Middle East, Africa, China, and India. There are more than 100 cannabinoids from hemp. The best known are the non-psychoactive cannabidiol (CBD) and the psychoactive tetrahydrocannabinol (THC).
Muchos ensayos clínicos informan de ios beneficios para la salud de los cannabinoides y, concretamente, del cannabidiol (CBD). Many clinical trials report the health benefits of cannabinoids and, specifically, cannabidiol (CBD).
En general, un primer paso para concentrar los cannabinoides del cáñamo es extraer el aceite de las hojas o de los los tricomas. Se utilizan diferentes metodologías, una de ellas es el tratamiento por presión y, posteriormente, se concentran con disolventes poco polares o con CO2 supercrítico. Los cannabinoides son más solubles en ios líquidos no polares. Esta característica facilita que se puedan utilizar disolventes eficaces como el hexano y el metanol, entre otros, para disolverlos, ya que polar disuelve a su polar. Una extracción tradicional es utilizar un disolvente como el hexano que extrae ios cannabinoides, pero también otras moléculas de semejante polaridad y, posteriormente, retirar el hexano con un rotavapor. El producto final es un aceite generalmente sólido a temperatura ambiente debido a la presencia de lípidos de alto masa molecular, generalmente ceras. Algunos de estos lípidos se pueden separar del resto del aceite mediante ciclos de congelación y descongelación, produciendo un aceite que es líquido a temperatura ambiente. Esta metodología permite obtener un aceite con una concentración desde el 2% hasta el 70% de cannabinoides, preferentemente desde el 20% hasta el 65%, dependiendo del proceso de concentración o purificación parcial. Posteriormente se pueden utilizar métodos cromatográficos para concentrar ios cannabinoides separándolos del resto de ios componentes presentes en el aceite. Los métodos cromatográficos permiten obtener ios cannabinoides con un grado de pureza superior al 95%, aun cuando consumen tiempo y tienen un coste elevado. Los cannabinoides que contiene el aceite de cáñamo, concretamente el cannabidiol (CBD) son poco polares y son insolubles en agua. Esta característica dificulta la absorción intestinal. In general, a first step in concentrating the cannabinoids in hemp is to extract the oil from the leaves or trichomes. Different methodologies are used, one of them is pressure treatment and, subsequently, they are concentrated with little polar solvents or with supercritical CO 2 . Cannabinoids are more soluble in nonpolar liquids. This feature makes it easy to use solvents effective as hexane and methanol, among others, to dissolve them, since polar dissolves its polar. A traditional extraction is to use a solvent such as hexane that extracts the cannabinoids, but also other molecules of similar polarity and, later, remove the hexane with a rotary evaporator. The final product is an oil that is generally solid at room temperature due to the presence of high molecular mass lipids, generally waxes. Some of these lipids can be separated from the rest of the oil through freeze-thaw cycles, producing an oil that is liquid at room temperature. This methodology makes it possible to obtain an oil with a concentration from 2% to 70% of cannabinoids, preferably from 20% to 65%, depending on the concentration or partial purification process. Afterwards, chromatographic methods can be used to concentrate the cannabinoids, separating them from the rest of the components present in the oil. Chromatographic methods make it possible to obtain cannabinoids with a purity level greater than 95%, even though they are time consuming and costly. The cannabinoids contained in hemp oil, specifically cannabidiol (CBD), are not very polar and are insoluble in water. This characteristic makes intestinal absorption difficult.
Para utilizar con mayor eficacia ¡os cannabinoides en alimentos, bebidas, complementos o suplementos alimenticios, cosmética o en medicina, es necesario microcapsular, nanocapsular o hacer micro y nanoemulsiones de los cannabinoides, entre otras metodologías y, siempre con un tamaño menor de 55 micrómetros para que puedan ser absorbidos por las vellosidades intestinales. Para producir micro y nanoemulsiones de los cannabinoides que contiene el aceite de cáñamo, es necesario micro y nanoemulsionar la fracción del aceite que contiene mayoritariamente los triglicéridos de los ácidos grasos. Para alcanzar este objetivo, se necesita una concenración elevada de surfactantes no iónicos generalmente en una relación de aceite / surfactante de 1 :9 para que la micro y nanoemulsión sea translúcida o transparente cuando se disuelve en agua, ya que no solo se micro y nanoemulsionan los cannabinoides si no que también, es necesario micro y nanoemulsionar ios triglicéridos. Si transformamos inicialmente los triglicéridos del aceite de cáñamo a di- y monoglicéridos de ácidos grasos, ácidos grasos sencillos y glicerol, entonces se necesitará utilizar una concentración mucho menor de surfactantes para micro y nanoemulsionar los cannabinoides ya que los di- y monoglicéridos, algunos ácidos grasos y el glicerol no solo se disuelven en agua porque son más polares si no que también actúan como surfactantes y cosurfactantes en el caso del glicerol Los aceites de cáñamo de diferente procedencia contienen altos niveles de ácido linoieico desde el 56% hasta el 60%, seguidos de los ácidos a-linolénico desde el 16% hasta el 20%, oleico desde el 10% hasta el 15%, palmítico desde el 5% hasta el 9%, esteárico desde el 2% hasta el 3%, g-linoiénico desde el 0,6% hasta el 2%, entre otros componentes. La mayoría de estos ácidos grasos están esterificados con glicerol formando triglicéridos. También pueden obtener cannabinoides, generalmente entre el 20% y el 50 Estos ácidos grasos esterificados del aceite de cáñamo son poco polares, y no se disuelven en agua. Para micro y nanoemulsionarlos junto con los cannabinoides, se necesita utilizar elevadas concentraciones de surfactantes y cosurfactantes. To more effectively use cannabinoids in food, beverages, supplements or food supplements, cosmetics or medicine, it is necessary to microcapsulate, nanocapsulate or make micro and nanoemulsions of cannabinoids, among other methodologies and, always with a size smaller than 55 micrometers so that they can be absorbed by the intestinal villi. To produce micro and nanoemulsions of the cannabinoids contained in hemp oil, it is necessary to micro and nanoemulsify the fraction of the oil that mainly contains the triglycerides of fatty acids. To achieve this goal, a high concentration of non-ionic surfactants is needed generally in an oil / surfactant ratio of 1: 9 for the micro and nanoemulsion to be translucent or transparent when dissolved in water, since they are not only micro and nanoemulsified cannabinoids if not also, it is necessary micro and nanoemulsify triglycerides. If we initially transform triglycerides from hemp oil to di- and monoglycerides of fatty acids, simple fatty acids, and glycerol, then a much lower concentration of surfactants will need to be used to micro and nanoemulsify cannabinoids since di- and monoglycerides, some acids Fatty acids and glycerol not only dissolve in water because they are more polar, but also act as surfactants and cosurfactants in the case of glycerol Hemp oils from different sources contain high levels of linoieic acid from 56% to 60%, followed by a-linolenic acids from 16% to 20%, oleic from 10% to 15%, palmitic from 5% to 9%, stearic from 2% to 3%, g-linolenic from 0.6% to 2%, among other components. Most of these fatty acids are esterified with glycerol to form triglycerides. They can also get cannabinoids, usually between 20 and 50%. These esterified fatty acids from hemp oil are low polar, and do not dissolve in water. To micro and nanoemulsify them together with cannabinoids, it is necessary to use high concentrations of surfactants and cosurfactants.
Es conocido que los lípidos de mayor masa molecular necesitan una concentración mayor de surfactantes para producir micro y nanoemulsiones, que los Iípidos de menor masa molecular. It is known that lipids with a higher molecular mass need a higher concentration of surfactants to produce micro and nanoemulsions than do lipids with a lower molecular mass.
Es conocido que la realización de una micro y nanoemulsión de un aceite en agua, que sea traslúcida o transparente, necesita de una concentración elevada de surfactante. Por ejemplo, para realizar una dispersión transparente de los fitocannabinoides del aceite de cáñamo en agua, se necesita una relación de peso de fitocannabinoides del aceite de cáñamo a emulgente no iónico de 1 :5 a 1 :10 000 (Water-soluble phytocannabinold formulations. Número de patente US9907823). It is known that the production of a micro and nanoemulsion of an oil in water, which is translucent or transparent, requires a high concentration of surfactant. For example, to make a transparent dispersion of hemp oil phytocannabinoids in water, a weight ratio of hemp oil phytocannabinoids to non-ionic emulsifier of 1: 5 to 1: 10,000 (Water-soluble phytocannabinold formulations. Patent number US9907823).
Por otra parte, se produce la lipolisis del aceite de cáñamo cuando se mezclan lipasas con el aceite. En algunos procedimientos como en la patente“Process for producing partial glyceride US 6,337,414”, se describe un proceso de glicerolisis de aceite o grasa utilizando una lipasa en presencia de agua, pero no utiliza una mezcla del aceite con el surfactante y la ¡ipasa disueltos en agua, como se realiza en la presente invención. El surfactante incrementa la superficie de contacto de la lipasa con el aceite y mejora la eficacia de la glicerolisis. Además, no reivindica su uso para el aceite de cáñamo. On the other hand, hemp oil lipolysis occurs when lipases are mixed with the oil. In some procedures, such as the patent "Process for producing partial glyceride US 6,337,414", a process of glycerolysis of oil or fat is described using a lipase in the presence of water, but it does not use a mixture of the oil. with the surfactant and the ipase dissolved in water, as performed in the present invention. The surfactant increases the contact surface of the lipase with the oil and improves the efficiency of glycerolysis. Also, it does not claim its use for hemp oil.
La patente de EE.UU "Nanoemulsion compositions and methods of use thereof (Número 1187,118,688) utiliza una composición de nanoemulsion que comprende una proteína o un complejo de fragmento de proteína y en donde la nanoemulsion contiene aceite de cáñamo, y al menos un fosfolípido seleccionado de un grupo que consiste en fosfatidilserina con una concentración igual o superior al 40% además, utiliza le fosfatidilserina porque desempeña un papel crítico en el mantenimiento del rendimiento mental óptimo y además, la formulación preferida es la inclusión de fosfolípidos ricos en fosfatidilserina en la fase oleosa después de la emulsificacíón. En la presente invención también se utiliza aceite de cáñamo, pero a diferencia de la patente anterior mencionada, utiliza la fosfatidilserina como un emulsificante y además a una concentración menor del 40%. The US patent "Nanoemulsion compositions and methods of use thereof (No. 1187,118,688) uses a nanoemulsion composition comprising a protein or protein fragment complex and wherein the nanoemulsion contains hemp oil, and at least one Phospholipid selected from a group consisting of phosphatidylserine with a concentration equal to or greater than 40% in addition, it uses phosphatidylserine because it plays a critical role in the maintenance of optimal mental performance and in addition, the preferred formulation is the inclusion of phospholipids rich in phosphatidylserine in the oil phase after emulsification Hemp oil is also used in the present invention, but unlike the above mentioned patent, it uses phosphatidylserine as an emulsifier and also at a concentration lower than 40%.
La solicitud de patente “Pre-spray emulsiona and powders containing non-polar compounds” Número: PCT/US2015/051097, también utiliza fosfatidilserina, pero a una concentración del 40% o superior. En la presente invención se utiliza fosfatidilserina a una concentración menor del 40%. The patent application "Pre-spray emulsifies and powders containing non-polar compounds" Number: PCT / US2015 / 051097, also uses phosphatidylserine, but at a concentration of 40% or higher. In the present invention, phosphatidylserine is used at a concentration of less than 40%.
La patente“Cochleates made witb soy phospbatidylserine” N°: 1189,775,907 utiliza fofatidilserína de soja que tiene un 40% a 74% de pureza y un catión multivalente. En la presente invención se utiliza fosfatidilserina con una pureza menor del 40% y no se utilizan cationes multivalentes. The patent "Cochleates made witb soy phospbatidylserine" No: 1189,775,907 uses soybean phosphatidylserine which is 40% to 74% pure and a multivalent cation. In the present invention phosphatidylserine with a purity of less than 40% is used and multivalent cations are not used.
DESCRIPCIÓN DE LA INVENCIÓN DESCRIPTION OF THE INVENTION
El primer aspecto de la presente invención es un procedimiento de obtención de una micro y nanoemulsion de un tamaño menor de 55 mm del aceite de cáñamo que comprende cannabínoides, caracterizado por que comprende las siguientes etapas: i. tratar un aceite de cáñamo que comprende cannabínoides, The first aspect of the present invention is a process for obtaining a micro and nanoemulsion of a size smaller than 55 mm from hemp oil comprising cannabinoids, characterized in that it comprises the following steps: i. treat a hemp oil that contains cannabinoids,
- con al menos una enzima lipasa que transforma los lípidos de mayor masa molecular a di- y monoglicéridos de ios ácidos grasos, ácidos grasos y glicerol, durante un tiempo de entre 1 minuto hasta 72 horas de tratamiento, y a una temperatura de entre 2 °C hasta 60 °C; - with at least one lipase enzyme that transforms the lipids with the highest molecular mass to di- and monoglycerides of fatty acids, fatty acids and glycerol, for a time of between 1 minute up to 72 hours of treatment, and at a temperature between 2 ° C and 60 ° C;
o or
transesterificar mediante un tratamiento químico con KOH o NaOH desde el 0,5% hasta el 1% en peso como catalizadores, en donde la relación de alcohol / aceite es desde 3:1 hasta 6:1 ; transesterifying by chemical treatment with KOH or NaOH from 0.5% to 1% by weight as catalysts, where the alcohol / oil ratio is from 3: 1 to 6: 1;
ii. añadir ai menos un antioxidante al producto obtenido en la etapa (i); y iii. aportar energía al producto obtenido en la etapa (ii), mediante un método seleccionado de entre agitación a una velocidad de agitación de entre 100 rpm hasta 30.000 rpm, donde el tiempo de actuación es de entre 10 segundos y 1 hora, o por ultrasonidos, a una potencia entre 20 y 3.000 watios y a una frecuencia entre 10 y 30 kHz durante un tiempo de sonicación de entre 5 segundos y 10 minutos. ii. adding at least one antioxidant to the product obtained in step (i); and iii. provide energy to the product obtained in stage (ii), by means of a method selected from stirring at a stirring speed of between 100 rpm and 30,000 rpm, where the action time is between 10 seconds and 1 hour, or by ultrasound, at a power between 20 and 3,000 watts and at a frequency between 10 and 30 kHz for a sonication time of between 5 seconds and 10 minutes.
En la presente invención se entiende por“emulsión” es una dispersión coloidal de dos líquidos inmiscibles, como el aceite y el agua, en forma de gotas. Si las gotas de aceite se dispersan finamente en agua, entonces se trata de una emulsión de aceite en agua. Cuando las gotas de agua se dispersan finamente en aceite, se trata de una emulsión de agua en aceite. In the present invention, "emulsion" is understood to be a colloidal dispersion of two immiscible liquids, such as oil and water, in the form of drops. If the oil droplets are finely dispersed in water, then it is an oil-in-water emulsion. When the water droplets are finely dispersed in oil, it is a water-in-oil emulsion.
En la presente invención se entiende por“micro y nanoemulsiones” hace referencia a la producción de una mezcla de micro y nanoemulsiones del aceite de cáñamo que contiene cannabinoides con el mismo procedimiento. Se distinguen de una emulsión en que son termodinámicamente estables a largo plazo sin aparente floculación o coalescencia, mientras que una emulsión es solo cinéticamente estable, es decir, que es lenta la velocidad a la cual la fase emulsionada se separa del agua. En general, se considera que las microemulsiones tienen diámetros de micrómetros y pueden ser transparentes o translúcidas. Las nanoemulsiones tienen diámetros de nanómetros y son transparentes. In the present invention, "micro and nanoemulsions" is understood to refer to the production of a mixture of micro and nanoemulsions of hemp oil containing cannabinoids with the same procedure. They differ from an emulsion in that they are thermodynamically stable in the long term without apparent flocculation or coalescence, whereas an emulsion is only kinetically stable, that is, the rate at which the emulsified phase separates from water is slow. In general, microemulsions are considered to have micrometer diameters and can be transparent or translucent. Nanoemulsions have nanometer diameters and are transparent.
En la presente invención se entiende por“aceite de cáñamo” se refiere al aceite extraído del cáñamo, principalmente de ios tricomas y preferentemente sin ceras en donde los cannabinoides pueden estar presentes desde el 5% hasta el 50%. En algunos ejemplos el aceite de cáñamo puede contener un 20% de cannabidiol. En la presente invención se entiende por“cáñamo” o cáñamo industria! es el nombre que reciben las variedades de la planta Cannabis: Cannabis sativa, Cannabis indica y Cannabis ruderalis. Se llama «cáñamo industrial» a las variedades de Cannabis destinadas a! uso industrial y alimentario. El cáñamo contiene cannabinoides entre otros muchos componentes. El cannabidiol, también conocido como CBD es uno de ios dos componentes cannabinoides más importantes de ia planta, que se encuentra en proporciones variables dependiendo de la cepa. In the present invention, "hemp oil" is understood to refer to oil extracted from hemp, mainly from trichomes and preferably without waxes, where cannabinoids can be present from 5% to 50%. In some examples, hemp oil may contain 20% cannabidiol. In the present invention it is understood by "hemp" or industrial hemp! is the name given to the varieties of the Cannabis plant: Cannabis sativa, Cannabis indica and Cannabis ruderalis. The varieties of Cannabis intended for! Is called "industrial hemp". industrial and food use. Hemp contains cannabinoids among many other components. Cannabidiol, also known as CBD is one of the two most important cannabinoid components of the plant, which is found in variable proportions depending on the strain.
En la presente invención se entiende por“cannabíonoides” son moléculas altamente lipofílicas con niveles muy bajos de solubilidad acuosa (2-15 mm / mL). Son susceptibles de degradación, especialmente en solución, a través de la acción de ia luz y la temperatura, así como a través de ia autooxidación. Se encuentra en las especies de Cannabis. Hay más de 100 cannabinoide procedentes del cáñamo. Los más conocidos son el cannabidiol no psicoactivo (CBD) y el psicoactivo tetrahidrocannabinol (THC). Tienen un amplio rango de aplicaciones para la salud humana y animal. In the present invention, "cannabíonoids" are understood to be highly lipophilic molecules with very low levels of aqueous solubility (2-15 mm / mL). They are susceptible to degradation, especially in solution, through the action of light and temperature, as well as through autoxidation. It is found in the Cannabis species. There are more than 100 cannabinoids from hemp. The best known are the non-psychoactive cannabidiol (CBD) and the psychoactive tetrahydrocannabinol (THC). They have a wide range of applications for human and animal health.
En la presente invención se entiende por “antioxidantes” se consideran ios antioxidantes naturales liposolubies reconocidos (tocoferoles, tocotrienoies, betacaroteno y coenzima Q10). In the present invention, "antioxidants" are understood as the recognized fat-soluble natural antioxidants (tocopherols, tocotrienies, beta-carotene and coenzyme Q10).
El aceite de cáñamo contiene principalmente triacilglicéridos de los ácidos grasos entre otras moléculas en porcentajes que pueden variar, dependiendo del método de producción, desde el 90% hasta el 50%. Los triglicéridos de ios ácidos grasos del aceite del aceite de cáñamo tienen mayor masa molecular que los diglicéridos y estos más que los monoglicéridos. Además, ios di- y monogüeéridos tienen cierta capacidad emulsionante. Monoglicéridos y diglicéridos son comúnmente añadidos a los productos comerciales de alimentos en pequeñas cantidades. Actúan como emulsionantes, ayudando a mezclar ios ingredientes insolubles que de otro modo no se mezclarían. Esta característica ayuda a disminuir ia concentración de los surfactantes para producir micro y nanoemulsiones del aceite de cáñamo. Hemp oil mainly contains triacylglycerides of fatty acids among other molecules in percentages that can vary, depending on the production method, from 90% to 50%. The triglycerides of the fatty acids in the oil of hemp oil have a higher molecular mass than the diglycerides and these more than the monoglycerides. Furthermore, the di- and monoguerides have a certain emulsifying capacity. Monoglycerides and diglycerides are commonly added to commercial food products in small amounts. They act as emulsifiers, helping to mix insoluble ingredients that would not otherwise mix. This characteristic helps to lower the concentration of surfactants to produce micro and nanoemulsions of hemp oil.
Un efecto emulsionante semejante a los di y monoglicéridos ios tienen los etil y ios metí! ésteres de los ácidos grasos (FAME, por sus siglas en inglés) Por tanto, se aprovechar el hecho de que el aceite de cáñamo contiene cannabidiol entre otros cannabinoides y triglicéridos, donde ambos grupos pueden estar en diferentes proporciones depende de la metodología de extracción. Como tal, el aceite (mezcla de cannabinoides y triglicéridos) es insoluble en agua. La ventaja que aporta este procedimiento es el tratamiento inicial enzimátieo con una lipasa para transformar ios triglicéridos en mono y diglicéridos que a su vez tienen capacidad emulsionante y por esta razón solo ese necesario utilizar una muy baja concentración de otros emulsionantes. An emulsifying effect similar to the di and monoglycerides ios have ethyl and ios methyl! fatty acid esters (FAME) Therefore, take advantage of the fact that hemp oil contains cannabidiol among other cannabinoids and triglycerides, where both groups can be in different proportions depending on the extraction methodology. As such, the oil (mixture of cannabinoids and triglycerides) is insoluble in water. The advantage provided by this procedure is the initial enzymatic treatment with a lipase to transform the triglycerides into mono and diglycerides that in turn have emulsifying capacity and for this reason it is only necessary to use a very low concentration of other emulsifiers.
El método se refiere a un proceso para producir micro y nanoemulsiones del aceite de cáñamo que contiene cannabinoides cuyos iípidos se han transformado a di- y monoglicéridos de los ácidos grasos o a etil o metíl ésteres de los ácidos grasos o combinación de ambos, para utilizar menor concentración de surfactantes y cosurfactantes para que se puedan dispersar los cannabinoides en una fase de agua o en una fase alimenticia sólida, y que tengan un diámetro menor de 55 micrómetros y que, además, se produzcan micro y nanoemulsiones translúcidas o transparentes en una fase de agua. The method refers to a process to produce micro and nanoemulsions of hemp oil containing cannabinoids whose iipids have been transformed into di- and monoglycerides of fatty acids or ethyl or methyl esters of fatty acids or a combination of both, to use less concentration of surfactants and cosurfactants so that cannabinoids can be dispersed in a water phase or in a solid food phase, and that they have a diameter less than 55 micrometers and that, in addition, translucent or transparent micro and nanoemulsions are produced in a phase of Water.
En una realización preferida del procedimiento de la presente invención las enzimas de la etapa i) son lipasas, que producen lipolisis, de origen animal, microbiano o vegetal, desde 5 unidades de lipasa por gramo de aceite a 12.000 unidades de lipasa por gramo de aceite y están en una cantidad de entre 0,2 g hasta 100 g por cada 100 litros de aceite. In a preferred embodiment of the process of the present invention, the enzymes of step i) are lipases, which produce lipolysis, of animal, microbial or plant origin, from 5 units of lipase per gram of oil to 12,000 units of lipase per gram of oil and they are in an amount of between 0.2 g to 100 g per 100 liters of oil.
Las enzimas Iipasas pueden actúar, por definición, en la interfaz orgánico-acuosa, catalizando la hidrólisis de los enlaces éster-carboxilato y liberando ácidos grasos y alcoholes orgánicos. En general las Iipasas catalizan la hidrólisis de los triacilgliceroles a di- y monogliceroles, y a ácidos grasos y glicerol de manera aleatoria, siendo ios productos intermedios mono- y diacilgliceroles. Iipase enzymes can act, by definition, at the organic-aqueous interface, catalyzing the hydrolysis of the ester-carboxylate bonds and releasing fatty acids and organic alcohols. In general, the Iipases catalyze the hydrolysis of triacylglycerols to di- and monoglycerols, and to fatty acids and glycerol in a random manner, the intermediate products being mono- and diacylglycerols.
Las lipasas pueden ser de origen animal (pancreático, hepático y gástrico), microbiano (bacterianas, fúngicas y de levadura) o vegetal, y varían en sus propiedades catalíticas. Existen diferentes tipos de lipasas. Lipasas específicas: tienen a ios ásteres de glicerol como sustratos específicos. Catalizan la hidrólisis de los triacilgliceroles, y también ios di- y monoacilgliceroles. Lipasas no específicas: catalizan ia hidrólisis completa de ios triacilgliceroles en ácidos grasos y glicerol de manera aleatoria, siendo los productos intermedios mono- y diacilgliceroles. Lipases can be of animal origin (pancreatic, liver, and gastric), microbial (bacterial, fungal, and yeast), or plant, and vary in their catalytic properties. There are different types of lipases. Specific lipases: have glycerol esters as specific substrates. They catalyze the hydrolysis of triacylglycerols, as well as di- and monoacylglycerols. Non-specific lipases: they catalyze the complete hydrolysis of the triacylglycerols into fatty acids and glycerol in a random way, the intermediate products being mono- and diacylglycerols.
Las lipasas se producen y proceden de páncreas porcino, de páncreas humano, de tejido adiposo de polio, de leche bovina, de germen de trigo. Lipasas derivadas de microorganismos de los géneros Rhizopus, Aspergillus y Mucor, fíhizopus delemar, fíhizopus oryzae, Rhizopus japonicus, Rhizopus niveus, Aspergillus niger, Asperfillus oryzae, Pseudomonas espacia, Pseudomonas fiuorescens, Candida rugosa, Candida antárctica, Candida lipolytica , BurkhoÍderia sp., Penicillium camemberti, Mucor javanicus y Mucor miehei. Lipases are produced and derived from porcine pancreas, human pancreas, polio adipose tissue, bovine milk, wheat germ. Lipases derived from microorganisms of the genera Rhizopus, Aspergillus, and Mucor, Phizopus delemar, Phizopus oryzae, Rhizopus japonicus, Rhizopus niveus, Aspergillus niger, Asperfillus oryzae, Pseudomonas espacia, Pseudomonas fiáruoresicatica, Candida antifaruoresica, Candida spolyk, fiáruorestica, Candida spolyk, fiáruorestica, Candida antifarica, Candida lipidia. Penicillium camemberti, Mucor javanicus and Mucor miehei.
La actividad de la lipasa se mide en U/mL. Actúan desde 5 unidades de lipasa por gramo de aceite a 12.000 unidades de lipasa por gramo de aceite, preferentemente entre 100 y 1.200 Ul por gramo, preferentemente de 100 U/g a 600 U/g y más preferentemente de 200 U/g hasta 400 U/g. La actividad de la lipasa depende de la procedencia de las lipasas. En otras lipasas, el intervalo de actividad varía desde 1.200 U/g hasta 1.800 U/g. En algunas realizaciones ia relación de lipasa tipo II porcina (100 a 500 Unidades/mg) a aceite, puede ser de 5-10 mg/mL, aunque en otra realización utiliza 10 gramos de aceite con 20 mL de agua y desde 1 ,5 g hasta 6 g de lipasa. El tiempo de actuación varía preferentemente desde 10 minutos hasta 120 horas, más preferentemente de 1 a 90 horas. Las lipasas funcionan desde temperatura ambiente a 20°C hasta 50°C, preferentemente entre 35°C y 50°C y se desactivan preferentemente a 90°C. Lipase activity is measured in U / mL. They act from 5 units of lipase per gram of oil to 12,000 units of lipase per gram of oil, preferably between 100 and 1,200 IU per gram, preferably from 100 U / g to 600 U / g and more preferably from 200 U / g to 400 U / g. The activity of the lipase depends on the origin of the lipases. In other lipases, the activity range varies from 1,200 U / g to 1,800 U / g. In some embodiments, the ratio of porcine type II lipase (100 to 500 Units / mg) to oil may be 5-10 mg / mL, although in another embodiment, it uses 10 grams of oil with 20 mL of water and from 1.5 g to 6 g of lipase. The actuation time preferably ranges from 10 minutes to 120 hours, more preferably 1 to 90 hours. Lipases operate from room temperature to 20 ° C to 50 ° C, preferably between 35 ° C and 50 ° C and are preferably inactivated at 90 ° C.
Dependiendo de la actividad, la lipasa se añade desde 0,2 g hasta 100 g por cada 100 litros, preferentemente desde 5 g hasta 20 g por cada 100 litros, y desde 1 minuto hasta 72 horas de tratamiento, preferentemnte desde 1 hora hasta 24 horas. Temperatura puede variar desde 2°C hasta 60°C, preferentemente desde 25°C hasta 40°C. Las lipasas transforman los lípidos de mayor masa molecular del aceite de cáñamo que contiene cannabinoides en productos de menor masa molecular. Las lipasas no transforman el cannabidiol. Depending on the activity, the lipase is added from 0.2 g to 100 g per 100 liters, preferably from 5 g to 20 g per 100 liters, and from 1 minute to 72 hours of treatment, preferably from 1 hour to 24 hours. Temperature can vary from 2 ° C to 60 ° C, preferably from 25 ° C to 40 ° C. Lipases transform the higher molecular weight lipids of hemp oil containing cannabinoids into lower molecular weight products. Lipases do not transform cannabidiol.
En otra realización preferida del procedimiento de la presente invención las enzimas lipasas de la etapa (i) se combinan con proteasas, amilasas o celulasas para disminuir ios pesos moleculares de las proteínas, polisacárido y celulosa residuales a péptidos o aminoácidos y a monosacáridos. In another preferred embodiment of the process of the present invention, the lipase enzymes of step (i) are combined with proteases, amylases or cellulases to decrease the molecular weights of the residual proteins, polysaccharides and cellulose to peptides or amino acids and monosaccharides.
En otra realización preferida del procedimiento de la presente invención las enzimas de la etapa (i) se utilizan en formato inmovilizado. In another preferred embodiment of the process of the present invention the enzymes of step (i) are used in immobilized format.
En otra realización preferida del procedimiento de la presente invención comprende añadir además al menos un surfactante en la etapa (i) en una cantidad de entre 1% y 25% en peso con respecto a la cantidad aceite de cáñamo inicial. In another preferred embodiment of the process of the present invention, it also comprises adding at least one surfactant in step (i) in an amount of between 1% and 25% by weight with respect to the initial hemp oil amount.
Las lipasas inmovilizadas son resistentes al calor y tienen una alta durabilidad en un amplio rango de concentraciones. Muchas de las lipasas y lipasas inmovilizadas están fácilmente disponibles como productos en el mercado. La cantidad de lipasa utilizada es preferiblemente de 0,1 a 30% en peso, particularmente de 1 a 15% en peso (200 a 100,000 unidades por gramo de aceite o grasa) en base a las materias primas para la reacción. En otra realización preferida del procedimiento de la presente invención en la transesterificación de la etapa (i) se produce una metonolisís o etanolisis y se realiza enzimáticamente con lipasas sin presencia de agua o en baja concentración. Immobilized lipases are heat resistant and have high durability over a wide range of concentrations. Many of the immobilized lipases and lipases are readily available as products on the market. The amount of lipase used is preferably 0.1 to 30% by weight, particularly 1 to 15% by weight (200 to 100,000 units per gram of oil or fat) based on the raw materials for the reaction. In another preferred embodiment of the process of the present invention, in the transesterification of step (i) a metonolysis or ethanolysis is produced and it is carried out enzymatically with lipases without the presence of water or in low concentration.
En otra realización preferida del procedimiento de la presente invención comprende una etapa adicional (ii') de añadir al menos un surfactante tras la etapa (ii) y antes de la etapa (iii), donde dicho surfactante es seleccionado de entre surfactante natural fosfatídicos y surfactante de origen animal. In another preferred embodiment of the process of the present invention, it comprises an additional step (ii ' ) of adding at least one surfactant after step (ii) and before step (iii), where said surfactant is selected from among natural phosphatidic surfactants and surfactant of animal origin.
En la presente invención se entiende por “surfactante, tensoactivo, emulgente o dispersante no iónico” se refiere a diferentes sinónimos de un agente generalmente anfifílico con una cabeza hidrófila y una cola hidrófoba con igual o diferente carácter hidrofílico o lipofílieo, que tiende a disminuir la tensión superficial entre dos fases y a ser no ionizado en soluciones neutras. Algunos ejemplos de tensiactivos no iónicos son el Tween 80, Tween 20, Span 80. Es conocido que los lípidos de mayor masa molecular necesitan mayor concentración de surfactantes para dispersarlos en micro y nanoemulsiones en una fase acuosa. Por ejemplo: los aceites de gran volumen mo¡ecular, como ¡os aceites de soja y girasol, pueden producir una pequeña región de microemulsión, mientras que el triglicérido de menor volumen molecular, la tributirina (butírico+glicerol), produce una gran región monofásica clara. In the present invention, "non-ionic surfactant, surfactant, emulsifier or dispersant" refers to different synonyms of a generally amphiphilic agent with a hydrophilic head and a hydrophobic tail with the same or different character. hydrophilic or lipophilic, which tends to decrease the surface tension between two phases and to be non-ionized in neutral solutions. Some examples of non-ionic surfactants are Tween 80, Tween 20, Span 80. It is known that lipids with a higher molecular mass need a higher concentration of surfactants to disperse them in micro and nanoemulsions in an aqueous phase. For example: high molecular volume oils, such as soybean and sunflower oils, can produce a small microemulsion region, while the lower molecular volume triglyceride, tributyrin (butyric + glycerol), produces a large region clear single phase.
En otra realización preferida del procedimiento de la presente invención si ¡os surfactantes de la etapa adicional (ii') se seleccionan de la lista que consiste en lecitina, fosfatidilserina, fosfatidilcolina, fosfatidiletanolamina, fosfatidilinositol, y ácido fosfatídico o sus combinaciones, adicionalmente se añaden en combinación con al menos: In another preferred embodiment of the process of the present invention, if the surfactants of additional step (ii ') are selected from the list consisting of lecithin, phosphatidylserine, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, and phosphatidic acid or their combinations, additionally they are added in combination with at least:
- un surfactante no iónico, seleccionado de entre Tween 20, Tween 40, Tween 80, Tween 80, Tween 21 , Tween 85, Tween 65, Tween 81 , Tween 61 y Tween 100; - a non-ionic surfactant, selected from among Tween 20, Tween 40, Tween 80, Tween 80, Tween 21, Tween 85, Tween 65, Tween 81, Tween 61 and Tween 100;
-un surfactante que se selecciona de la lista que consiste en Span 20, Span 40, Span 60, Span 85, y Span 85; - a surfactant that is selected from the list consisting of Span 20, Span 40, Span 60, Span 85, and Span 85;
-un sulfactante que se selecciona de la lista que consiste en almidones, caseinato de leche, leche en polvo, proteína de soja, proteína de guisante y proteína de suero; o - a sulfactant that is selected from the list consisting of starches, milk caseinate, milk powder, soy protein, pea protein and whey protein; or
-cualquiera de sus combinaciones; y -any of its combinations; Y
donde ia reiación en peso del total de surfactantes y aceite de cáñamo varia desde 10:1 hasta 1 :100. where the weight ratio of total surfactants and hemp oil ranges from 10: 1 to 1: 100.
En otra realización preferida del procedimiento de la presente invención comprende añadir ai menos un cosurfactante, donde dicho cosurfacante se selecciona del grupo etanol, metanol, xilitol, sorbitol, glicerol, maítitol o eritritol, o cualquiera de sus combinaciones. In another preferred embodiment of the process of the present invention, it comprises adding at least one cosurfactant, where said cosurfactant is selected from the group ethanol, methanol, xylitol, sorbitol, glycerol, maititol or erythritol, or any of their combinations.
En la presente invención se entiende por“cosurfactante” generalmente son alcoholes o aminas dentro del intervalo C4 a C10 que ayudan a la formación y a la estabilización de las micro y nanoemulsiones. Ejemplos: etanoi (C2), glicerol (C3), xilitol (C5), eritritol (C4). La producción de ásteres etílicos o metílicos de los ácidos grasos (FAME por sus siglas en inglés) desde el aceite de cáñamo utilizando metodologías de etanolisis o metanolisis. La metanolisis de un compuesto graso, es el resultado de tres reacciones consecutivas: transesterificación parcial del triglicérido (TG) para formar ei diglícérido (DG), transesterificación parcial del DG para formar el monoglicérido (MG), y transesterificación parcial dei MG para formar el FAME y glicerol (G). Para la producción de los FAME se necesitan de 0,5% a 1% de KGH o NaOH como catalizador etanol o metanol. Los compuestos grasos deben tener un valor ácido menor a 1 mg KOH/g. La relación de alcohol / aceite varía preferentemente desde 3:1 hasta 6:1. El tiempo de duración de 0,1 horas de la reacción a una temperatura de 60°C tiene una eficacia de producción de FAME del 94%. In the present invention, "cosurfactant" is generally understood to be alcohols or amines within the C4 to C10 range that help the formation and stabilization of micro- and nanoemulsions. Examples: ethanoi (C2), glycerol (C3), xylitol (C5), erythritol (C4). The production of fatty acid ethyl or methyl esters (FAME) from hemp oil using ethanolysis or methanolysis methodologies. The methanolysis of a fatty compound is the result of three consecutive reactions: partial transesterification of the triglyceride (TG) to form the diglyceride (DG), partial transesterification of the DG to form the monoglyceride (MG), and partial transesterification of the MG to form the FAME and glycerol (G). For the production of FAME, 0.5% to 1% KGH or NaOH are needed as catalyst, ethanol or methanol. Fatty compounds must have an acid value less than 1 mg KOH / g. The alcohol / oil ratio preferably ranges from 3: 1 to 6: 1. The reaction time of 0.1 hours at a temperature of 60 ° C has a FAME production efficiency of 94%.
Los FAME pueden utilizarse como solventes y ayudan a la dispersión de los cannabinoides que se encuentran en el aceite de cáñamo y, de esta forma, se necesita una menor concentración de cosurfactantes, de surfactantes como las iecitinas o sus derivados, de biosurfactantes, de surfactantes naturales, de surfactantes con certificado ecológicos, y de surfactantes sintéticos como ios Tweens o los Spans, y sus combinaciones, para la producción de micro y nanoemulsiones de ios cannabinoides presentes en el aceite de cáñamo. FAME can be used as solvents and help the dispersion of cannabinoids found in hemp oil and, in this way, a lower concentration of cosurfactants is needed, of surfactants such as iecithins or their derivatives, of biosurfactants, of surfactants natural, certified organic surfactants, and synthetic surfactants such as ios Tweens or Spans, and their combinations, for the production of micro and nanoemulsions of ios cannabinoids present in hemp oil.
Se ha encontrado que se puede utilizar una concentración menor de surfactantes no iónicos, naturales o ecológicos, que en las metododogías actuales cuando al aceite de cáñamo transformado según las metodologías anteriores. Por ejemplo, ai aceite de cáñamo se le añade una mezcla de dos fosfoíípidos como la mezcla de fosfatidiíserina / fosfatídilcolina en una relación desde 1 :10 hasta 35:65, preferentemente de 1 :5 en una concentración desde el 1 % hasta ei 39% y otro surfactante no fosfolipídico para producir micro y nanoemuísiones. Otro ejempío es: fosfatidiíserina / fosfatidiícolina y Tween 80, o fosfatidiíserina / fosfatídilcolina y almidón modificado o fosfatidiíserina / fosfatídilcolina y goma arábica. It has been found that a lower concentration of non-ionic, natural or ecological surfactants can be used than in current methodologies when using hemp oil processed according to the above methodologies. For example, to hemp oil is added a mixture of two phosphoipids such as the phosphatidiyserine / phosphatidylcholine mixture in a ratio from 1: 10 to 35:65, preferably 1: 5 in a concentration from 1% to 39%. and another non-phospholipid surfactant to produce micro and nano emmisions. Another example is: phosphatidiyserine / phosphatidiicholine and Tween 80, or phosphatidiyserine / phosphatidylcholine and modified starch or phosphatidiyserine / phosphatidylcholine and gum arabic.
La fosfatidiíserina es un componente natural de todas las membranas biológicas y está más concentrada en ei cerebro. Los fosfoíípidos utilizados pueden producirse sintéticamente o prepararse a partir de fuentes naturales. Las Iecitinas, fosfatidil colina y fosfatidiíserina se consideran Generalmente Reconocido como Seguro (GRAS). Ambas derivan de Iecitinas de origen vegetal o animal y son adecuadas para realizar emulsiones de rango micrométrico o nanométrico de los aceites vegetales y animales. En otras realizaciones no limitantes, la fosfatidilserina puede ser sustituida por fosfatidiletanolamina, fosfatidllinositol, fosfatidilserina y ácido fosfatídico o combinados con ella. Phosphatidiserine is a natural component of all biological membranes and is most concentrated in the brain. The phosphoipids used can be produced synthetically or prepared from natural sources. Lecithins, phosphatidyl choline and phosphatidiyserine are considered Generally Recognized as Safe (GRAS). Both are derived from lecithins of plant or animal origin and are suitable for performing emulsions of micrometric or nanometric range of vegetable and animal oils. In other non-limiting embodiments, phosphatidylserine can be substituted for or combined with phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, and phosphatidic acid.
Por lo que se utilizan en la presente invención surfactantes de origen natural como son ios fosfolípidos y cosurfactantes como puede ser el glicerol, para disminuir el uso de los surfactantes no iónicos para producir dichas emulsiones. Aunque los surfactantes no iónicos son generalmente seguros, los consumidores demandan alimentos, bebidas, complementos o suplementos alimenticios, cosmética y medicina con bajas concentraciones de surfactantes no iónicos y a ser posible surfactantes naturales y mejor aún con denominación ecológica. For this reason, surfactants of natural origin such as phospholipids and cosurfactants such as glycerol are used in the present invention to reduce the use of non-ionic surfactants to produce said emulsions. Although non-ionic surfactants are generally safe, consumers demand food, beverages, supplements or food supplements, cosmetics and medicine with low concentrations of non-ionic surfactants and, if possible, natural surfactants and better yet with an ecological name.
En otra realización preferida del procedimiento de la presente invención además comprende una etapa adicional (iv) posterior a la etapa (iii), de añadir un agente secante, seleccionado de entre maltodextrinas, glucosa, lactosa, maltitol, xilitol, eritritol, fructosa, metil celulosa, hidroxipropilmetilcelulosa, monofosfato, difosfato, trifosfato, polifosfato, cítrico, citratos, ascórbico, ascorbato, celulosa microcristalina, proteína de suero, proteína de leche, proteína de cáñamo, proteína de guisante, proteína de soja, leche en polvo o en sus combinaciones para que la emulsión esté en forma de polvo, en una relación en peso emulsificante/aceite de entre 4:1 a 7:1 , y posteriormente moler en molino de alta velocidad, molino de martillo, molino de rodillos, molino de disco, molino de bolas, mortero, o cualquier molino de alimentos con tipos de proceso fino o ultrafino. En una realización más preferida el secante es seleccionado de entre monofosfato, difosfato, trifosfato, polifosfato, cítrico, citratos, ascórbico, ascorbato. In another preferred embodiment of the process of the present invention, it also comprises an additional step (iv) subsequent to step (iii), of adding a drying agent, selected from maltodextrins, glucose, lactose, maltitol, xylitol, erythritol, fructose, methyl cellulose, hydroxypropylmethylcellulose, monophosphate, diphosphate, triphosphate, polyphosphate, citric, citrates, ascorbic, ascorbate, microcrystalline cellulose, whey protein, milk protein, hemp protein, pea protein, soy protein, milk powder or combinations thereof so that the emulsion is in powder form, in an emulsifier / oil weight ratio between 4: 1 to 7: 1, and later grinding in high speed mill, hammer mill, roller mill, disk mill, mill ball, mortar, or any food mill with fine or ultrafine process types. In a more preferred embodiment the desiccant is selected from among monophosphate, diphosphate, triphosphate, polyphosphate, citric, citrates, ascorbic, ascorbate.
Al añadir cualquier secante en la relación en peso indicada el volumen final aumenta del orden de 10 veces el volumen inicial, sin embargo, si el secante es seleccionado de entre monofosfato, difosfato, trifosfato, polifosfato, cítrico, citratos, ascórbico, ascorbato el volumen aumenta menos de el doble, facilitando la formación de la micro y nanoemulsión. When adding any desiccant in the indicated weight ratio, the final volume increases in the order of 10 times the initial volume, however, if the desiccant is selected from among monophosphate, diphosphate, triphosphate, polyphosphate, citric, citrates, ascorbic, ascorbate the volume increases less than double, facilitating the formation of the micro and nanoemulsion.
En otra realización preferida del procedimiento de la presente invención además comprende una etapa adicional (v) . de dispersar el producto obtenido en la etapa (iii) o (iv) en una fase acuosa; o In another preferred embodiment of the process of the present invention, it also comprises an additional step (v) . of dispersing the product obtained in step (iii) or (iv) in an aqueous phase; or
. de absorber el producto obtenido en la etapa (iii) o (iv) en una fase sólida desde 5 mg en 100 mL hasta 10 g en 100 mL produciendo emulsiones transparentes. . to absorb the product obtained in stage (iii) or (iv) in a solid phase from 5 mg in 100 mL to 10 g in 100 mL, producing transparent emulsions.
En la presente invención se entiende por“claro o transparente" hace referencia a una solución acuosa que contiene el compuesto lipofílico en una solución que contiene agua que está libre de partículas visibles de compuesto disperso (no disueito). In the present invention, "clear or transparent" is understood to refer to an aqueous solution containing the lipophilic compound in a water-containing solution that is free of visible particles of dispersed (non-dissolute) compound.
En otra realización más preferida del procedimiento de la presente invención además comprende añadir al menos una ciclodextrina en una cantidad en porcentaje en peso de entre el 5% y el 400% con respecto al aceite de cáñamo inicial, seleccionado de entre a-Ciclodextrina, b-Ciclodextrina, y-Ciclodextrina, d-Ciclodextrina y derivados como 2-Hidroxipropil- b -ciclodextrina, 2, Hydroxyethyl- b-iclodextrina, 2-Hidroxipropil- y-ciclodextrina, 2-Hidroxipropil-a-ciclodextrina, Metil-b-ciclodextrina, Carboximetil-b- ciclodextrina sai sódica, 2-Carboxietil- b-iclodextrina, sal sódica, Acetii- b-iclodextrina, Succinil--ciclodextrina, Succinil-a-ciclodextrina, Butil- b-iclodextrina o Butil-y- ciclodextrina y cualquier combinación de los anteriores, In another more preferred embodiment of the process of the present invention, it further comprises adding at least one cyclodextrin in an amount in percentage by weight of between 5% and 400% with respect to the initial hemp oil, selected from a-Cyclodextrin, b -Cyclodextrin, y-Cyclodextrin, d-Cyclodextrin and derivatives such as 2-Hydroxypropyl- b-cyclodextrin, 2, Hydroxyethyl- b-iclodextrin, 2-Hydroxypropyl- y-cyclodextrin, 2-Hydroxypropyl-a-cyclodextrin, Methyl-b-cyclodextrin , Carboxymethyl-b-cyclodextrin sodium sai, 2-Carboxyethyl-b-iclodextrin, sodium salt, Acetii- b-iclodextrin, Succinyl-cyclodextrin, Succinyl-a-cyclodextrin, Butyl-b-iclodextrin or Butyl-y-cyclodextrin and any combination of the above,
• justo antes de la etapa (v); o • just before stage (v); or
• ai producto obtenido de la etapa (v); • the product obtained from step (v);
La emulsión liquida o sólida tiene el olor y el sabor característico del cáñamo. La eliminación o supresión del sabor y el olor, puede proporcionar una ventaja frente a otros procedimientos. El olor y el sabor característico a cáñamo de la emulsión, se puede eliminar o suprimir utilizando ciclodextrinas. Las ciclodextrinas son monosacáridos unidos en forma de anillo (oligosacáridos cíclicos) de 5 o más unidades de a-D-glucopiranósido (glucosa cíclica). The liquid or solid emulsion has the characteristic smell and taste of hemp. The removal or suppression of taste and odor can provide an advantage over other procedures. The characteristic hemp odor and taste of the emulsion can be removed or suppressed using cyclodextrins. Cyclodextrins are ring-bound monosaccharides (cyclic oligosaccharides) of 5 or more α-D-glucopyranoside (cyclic glucose) units.
Aún cuando las ciclodextrinas se utilizan en la industria farmacéutica para aumentar la solubilidad de algunos fármacos en agua, también se pueden utilizar para atrapar moléculas volátiles relacionadas con el olor y moléculas relacionadas con el sabor. Although cyclodextrins are used in the pharmaceutical industry to increase the solubility of some drugs in water, they can also be used to trap volatile odor-related molecules and taste-related molecules.
Un segundo aspecto de la presente invención es una micro y nanoemulsión obtenida según el procedimiento descrito anteriormente. Un tercer aspecto de la presente invención es refiere a una micro y nanoemulsión (a partir de aquí la emulsión de la presente invención) caracterizada por que comprendeA second aspect of the present invention is a micro and nanoemulsion obtained according to the procedure described above. A third aspect of the present invention refers to a micro and nanoemulsion (henceforth the emulsion of the present invention) characterized in that it comprises
• al menos un cannabinoide en una cantidad en porcentaje en peso respecto al total de la emulsión de entre 5% y 50%; • at least one cannabinoid in an amount in percentage by weight with respect to the total emulsion of between 5% and 50%;
• monoglicéridos y diglicéridos; • monoglycerides and diglycerides;
• ácidos grasos; • fatty acids;
• glicerol; • glycerol;
• al menos un antioxidante; • at least one antioxidant;
• etil o metil ásteres de los ácidos grasos o sus combinaciones; y • ethyl or methyl esters of fatty acids or their combinations; Y
• opcionalmente al menos una enzima, preferiblemente una lipasa; • optionally at least one enzyme, preferably a lipase;
donde dichas micro y nanoemulsiones tienen un tamaño menor de 55 mm. where said micro and nanoemulsions have a size smaller than 55 mm.
En otra realización preferida de la emulsión de la presente invención la enzima es una lipasa y se selecciona de entre lipasas de origen animal, microbiano o vegetal. In another preferred embodiment of the emulsion of the present invention, the enzyme is a lipase and is selected from lipases of animal, microbial or plant origin.
En otra realización preferida de la emulsión de la presente invención además comprende otras enzimas seleccionadas de entre proteasas, amilasas, celulasas y cualquier combinación de las anteriores. In another preferred embodiment of the emulsion of the present invention it also comprises other enzymes selected from among proteases, amylases, cellulases and any combination of the above.
En otra realización preferida de la emulsión de la presente invención ei cannabinoide es cannabidiol. In another preferred embodiment of the emulsion of the present invention, the cannabinoid is cannabidiol.
En otra realización preferida de la emulsión de la presente invención además comprende al menos un surfactante, preferiblemente seleccionado de entre surfactante natural fosfatídicos, surfactante de origen animal y cualquier combinación, y más preferiblemente surfactante natural fosfatídicos en combinación con un surfactante no iónico. In another preferred embodiment of the emulsion of the present invention it further comprises at least one surfactant, preferably selected from natural phosphatidic surfactant, surfactant of animal origin and any combination, and more preferably natural phosphatidic surfactant in combination with a non-ionic surfactant.
En otra realización preferida de la emulsión de la presente invención además comprende al menos un cosurfactante, preferiblemente seleccionado de entre etanol, metanol, xilitol, sorbitol, glicerol, maltitol o eritritol, o en sus combinaciones. In another preferred embodiment of the emulsion of the present invention, it further comprises at least one cosurfactant, preferably selected from ethanol, methanol, xylitol, sorbitol, glycerol, maltitol or erythritol, or their combinations.
En otra realización preferida de la emulsión de la presente invención el antioxidante, es seleccionado de entre tocoferoles, tocoferoles alfa, beta, gamma o delta, tocotrienoles, tocotrienoles alfa, beta, gamma o delta, astaxantina, fosfolípidos, ubiquinol, ubiquinona, glutatión, y sus combinaciones. En otra realización preferida de la emulsión de la presente invención además comprende al menos un agente emulsificante, preferiblemente seleccionado de entre maltodextrina, glucosa, lactosa, maititol, xilitol, eritritoí, fructosa, metil celulosa, hidroxipropilmetilcelulosa, celulosa microcristalina, proteína de suero, proteína de leche, proteína de cáñamo, proteína de guisante, proteína de soja, leche en polvo o en sus combinaciones. In another preferred embodiment of the emulsion of the present invention, the antioxidant is selected from tocopherols, alpha, beta, gamma or delta tocopherols, tocotrienols, alpha, beta, gamma or delta tocotrienols, astaxanthin, phospholipids, ubiquinol, ubiquinone, glutathione, and their combinations. In another preferred embodiment of the emulsion of the present invention, it also comprises at least one emulsifying agent, preferably selected from maltodextrin, glucose, lactose, maititol, xylitol, erythrite, fructose, methyl cellulose, hydroxypropylmethylcellulose, microcrystalline cellulose, whey protein, protein milk, hemp protein, pea protein, soy protein, milk powder or their combinations.
En otra realización preferida de la emulsión de la presente invención además comprende ai menos una ciclodextrina en una cantidad en porcentaje en peso de entre el 5% y el 400% con respecto al aceite de cáñamo inicial, seleccionado de entre a- Ciclodextrina, b-iclodextrina, y-Ciclodextrina, s- Ciclodextrina y derivados como 2- Hidroxipropil· b-iclodextrina, 2, Hydroxyethyl- b-iclodextrina, 2-Hidroxipropii-y- ciclodextrina, 2-Hidroxipropil-a-ciclodextrina, Metil-b-iclodextrina, Carboximetii-b- ciclodextrina sai sódica, 2-Carboxietil- b-iclodextrina, sal sódica, Acetil- b-iclodextrina, Succinil- b-iclodextrina, Succinil-a-ciclodextrina, Butil- b-iclodextrina, o Butil-y- ciclodextrina y cualquier combinación de los anteriores In another preferred embodiment of the emulsion of the present invention, it also comprises at least one cyclodextrin in an amount in percentage by weight of between 5% and 400% with respect to the initial hemp oil, selected from a- Cyclodextrin, b- iclodextrin, y-Cyclodextrin, s- Cyclodextrin and derivatives such as 2- Hydroxypropyl b-iclodextrin, 2, Hydroxyethyl- b-iclodextrin, 2-Hydroxypropyl-y- cyclodextrin, 2-Hydroxypropyl-a-cyclodextrin, Methyl-b-iclodextrin Carboxymethii-b- cyclodextrin sodium sodium, 2-Carboxyethyl-b-iclodextrin, sodium salt, Acetyl-b-iclodextrin, Succinyl-b-iclodextrin, Succinyl-a-cyclodextrin, Butyl-b-iclodextrin, or Butyl-and-cyclodextrin and any combination of the above
En otra realización preferida de la emulsión de la presente invención el monoglicérido y diglicérido, los ácidos grasos y el glicerol, son producto de la reacción del aceite de cáñamo con enzimas. In another preferred embodiment of the emulsion of the present invention, the monoglyceride and diglyceride, the fatty acids and the glycerol, are the product of the reaction of hemp oil with enzymes.
Un cuarto aspecto de ia presente invención es una composición que comprende ia micro y nanoemulsión descrita según ia presente invención. A fourth aspect of the present invention is a composition comprising the micro and nanoemulsion described according to the present invention.
En una realización preferida de la composición dicha composición es un alimento, una bebida, un complemento o suplemento alimenticio, una composción cosmética o una composción farmacéutica. In a preferred embodiment of the composition, said composition is a food, a beverage, a food supplement or supplement, a cosmetic composition or a pharmaceutical composition.
En una realización aún más preferida de la composición, la bebida se selecciona del grupo que consiste en bebida energética, agua potable o mineral, limonada, agua tónica, agua de fruta, jugo de fruta, leche, suero de leche, bebida gaseosa y bebida alcohólica. EJEMPLOS In an even more preferred embodiment of the composition, the beverage is selected from the group consisting of energy drink, drinking or mineral water, lemonade, tonic water, fruit water, fruit juice, milk, buttermilk, carbonated drink and soft drink. alcoholic. EXAMPLES
En algunas realizaciones, el aceite de cáñamo emulsionado está presente en una formulación dispersado en agua, por ejemplo, en una bebida a una concentración desde el 0,001% en peso hasta el 10% en peso, preferentemente desde 0,05% hasta 0,2%. In some embodiments, the emulsified hemp oil is present in a formulation dispersed in water, for example, in a beverage at a concentration from 0.001% by weight to 10% by weight, preferably from 0.05% to 0.2 %.
La composición de la formulación puede estar en cualquier formato de dosificación oral o dérmica. Las preparaciones orales líquidas incluyen, líquidos, bebidas, jarabes, suspensiones, geles, etc., adecuados para quién los ingiera. The composition of the formulation can be in any oral or dermal dosage format. Oral liquid preparations include liquids, beverages, syrups, suspensions, gels, etc., suitable for whoever ingests them.
Una formulación soluble en agua como se describe en el presente documento puede pulverizarse directamente sobre la piel. A water soluble formulation as described herein can be sprayed directly onto the skin.
En otras realizaciones no limitantes de la presente invención, el aceite de cáñamo emulsionado se mezcla con, maltodextrina, glucosa, lactosa, maltitol, xilitol, eritritol, fructosa, metil celulosa, hidroxipropilmefilcelulosa, celulosa mícrocrístalina, proteína de suero, proteína de leche, proteína de cáñamo, proteína de guisante, proteína de soja, leche en polvo o en sus combinaciones para obtener un polvo seco. En estas realizaciones, la formulación dispersada en agua está en una concentración desde el 0,005% hasta el 10%, preferentemente desde el 0,1 % hasta el 2%. In other non-limiting embodiments of the present invention, the emulsified hemp oil is mixed with, maltodextrin, glucose, lactose, maltitol, xylitol, erythritol, fructose, methyl cellulose, hydroxypropylmefilcellulose, microcrystalline cellulose, whey protein, milk protein, protein of hemp, pea protein, soy protein, milk powder or in their combinations to obtain a dry powder. In these embodiments, the formulation dispersed in water is in a concentration of from 0.005% to 10%, preferably from 0.1% to 2%.
Ejemplo 1 : micro y nanoemulsiones. Example 1: micro and nanoemulsions.
Grupo A: 100 g de aceite de cáñamo que contiene 30% de cannabidiol. Group A: 100 g of hemp oil containing 30% cannabidiol.
Grupo B: 400 Ul/g de lípasa pancreática o bacteriana disuelta en 20 mL de agua y 5 g de Tween 80. Group B: 400 IU / g of pancreatic or bacterial lipase dissolved in 20 mL of water and 5 g of Tween 80.
El grupo A y B se mezcla con agitación durante 24 horas y a 30°C de temperatura. Calentar a 90 °C para desactivar las enzimas Group A and B are mixed with stirring for 24 hours and at a temperature of 30 ° C. Heat to 90 ° C to deactivate the enzymes
Añadir 10 g de fosfatidilserina / fosfatidiicolina en relación 1 :5, 20 g de Tween 80 y 5 g de glicerol. Add 10 g of phosphatidylserine / phosphatidiicoline in a ratio of 1: 5, 20 g of Tween 80 and 5 g of glycerol.
Agitar a 3000 rpm durante 5 minutos. En otra realización se puede utilizar ultrasonidos. Se obtienen micro y nanoemulsiones líquidas. Shake at 3000 rpm for 5 minutes. In another embodiment, ultrasound can be used. Liquid micro and nanoemulsions are obtained.
En esta realización, 0,1 mL de las micro y nanoemulsiones líquidas, se dispersan en 100 mL de una bebida. Para producir un producto en polvo de las micro y nanoemulsiones liquidas, se mezclan 250 de maltodextrina con 50 mL de las micro y nanoemulsiones. En esta realización, 0,8 g de la micro y nanoemulsión en polvo se mezcla con 100 g de un alimento, bebida, complemento o suplemento alimenticios, producto de cosmética o medicamento. In this embodiment, 0.1 mL of the liquid micro and nanoemulsions are dispersed in 100 mL of a beverage. To produce a powdered product of the liquid micro and nanoemulsions, 250 of maltodextrin are mixed with 50 mL of the micro and nanoemulsions. In this embodiment, 0.8 g of the micro and nanoemulsion powder is mixed with 100 g of a food, drink, food supplement or supplement, cosmetic product or medicine.
Ejemplo 2: micro y nanoemulsiones con aceite de cáñamo previamente transesterificado. Example 2: micro and nanoemulsions with previously transesterified hemp oil.
Como en el ejemplo 1 , pero en vez de producir una lipolisis se produce una metanolisis mediante una transesterificación estándar con NaOH y metanol. El metanol sobrante se retira mediante un rotavapor. As in example 1, but instead of producing a lipolysis, a methanolysis occurs through a standard transesterification with NaOH and methanol. Excess methanol is removed using a rotary evaporator.
Se dispersan 0,1 mL de las micro y nanoemulsiones líquidas, en 100 mL de un serum de cosmética. 0.1 mL of the liquid micro and nanoemulsions are dispersed in 100 mL of a cosmetic serum.
Y por otro lado Para producir polvo de las micro y nanoemulsiones se añaden 250 de celulosa mlcrocrlstalina y estearato de magnesio con 50 mL de las micro y nanoemulsiones. And on the other hand, to produce powder for the micro and nanoemulsions, 250 ml of cellulose, microcrystalline and magnesium stearate are added with 50 mL of the micro and nanoemulsions.
En esta realización, 0,8 g de la micro y nanoemulsión en polvo se mezcla con 100 g de un alimento, bebida, complemento o suplemento alimenticios, producto de cosmética o medicamento. In this embodiment, 0.8 g of the micro and nanoemulsion powder is mixed with 100 g of a food, drink, food supplement or supplement, cosmetic product or medicine.
Ejemplo 3: micro y nanoemulsiones con surfactantes naturales. Example 3: micro and nanoemulsions with natural surfactants.
Como en el ejemplo 1 , pero en vez de utilizar Tween 80 se utiliza Quillaja japónica (8%) como surfactaníe y glicerol (8%) como cosurfactante. As in example 1, but instead of using Tween 80, Quillaja japonica (8%) is used as surfactant and glycerol (8%) as cosurfactant.
A continuación, se dispersan 0,1 mL de las micro y nanoemulsiones líquidas, en 100 mL de un serum de cosmética. Next, 0.1 mL of the liquid micro and nanoemulsions are dispersed in 100 mL of a cosmetic serum.
Y por otro lado para producir polvo de las micro y nanoemulsiones se añaden 250 de leche desnatada en polvo con 50 mL de las micro y nanoemulsiones y se mezclan 0,8 g de la micro y nanoemulsión en polvo con 100 g de un alimento, bebida, complemento o suplemento alimenticios, producto de cosmética o medicamento. And on the other hand, to produce powder from the micro and nanoemulsions, 250 of skimmed milk powder are added with 50 mL of the micro and nanoemulsions and 0.8 g of the micro and nanoemulsion powder are mixed with 100 g of a food, drink , food supplement or supplement, cosmetic product or medicine.
Ejemplo 4: micro y nanoemulsiones Example 4: micro and nanoemulsions
Grupo A: 100 g de aceite de cáñamo cuando ia cantidad de de cannabidiol es inferior a 20%. Grupo B: 400 lil/g de lipasa pancreática o bacteriana disuelta en 20 mL de agua. Group A: 100 g of hemp oil when the amount of cannabidiol is less than 20%. Group B: 400 lil / g of pancreatic or bacterial lipase dissolved in 20 mL of water.
El grupo A y B se mezcla con agitación durante 24 horas y a 30°C de temperatura. Calentar a 90 °C para desactivar ias enzimas Group A and B are mixed with stirring for 24 hours and at a temperature of 30 ° C. Heat to 90 ° C to deactivate the enzymes
Se obtienen micro y nanoemulsiones líquidas. Liquid micro and nanoemulsions are obtained.
Ejemplo 5: Micro y nanoemulsiones directas Example 5: Micro and direct nanoemulsions
A 100 g de aceite de cáñamo que contiene 30% de cannabidiol se le añaden 1.000 Ul/g de lipasa bacteriana con 0.1 % de agua y 4% del cosurfactante glicerol. El pH se ajusta a 7 con NaOH. Se incuba la mezcla a una temperatura de 50°C durante 14 horas y a 600 rpm. Posteriormente la enzima se desactiva a 90°C. La emulsión se agita a 3.000 rpm durante 5 minutos. To 100 g of hemp oil containing 30% cannabidiol, 1,000 IU / g of bacterial lipase with 0.1% of water and 4% of the cosurfactant glycerol are added. The pH is adjusted to 7 with NaOH. The mixture is incubated at a temperature of 50 ° C for 14 hours and at 600 rpm. The enzyme is subsequently deactivated at 90 ° C. The emulsion is stirred at 3,000 rpm for 5 minutes.
En esta realización, 0,1 mL de las micro y nanoemulsiones líquidas, se dispersan en 100 mL de una bebida. In this embodiment, 0.1 mL of the liquid micro and nanoemulsions are dispersed in 100 mL of a beverage.
Para producir un producto en polvo de las micro y nanoemulsiones líquidas, se mezclan 250 de maltodextrina con 50 mL de las micro y nanoemulsiones. En esta realización, 0,8 g de ias micro y nanoemulsión en polvo se mezcla con 100 g de un alimento, bebida, complemento o suplemento alimenticio, producto de cosmética o medicamento. To produce a powder product of the liquid micro and nanoemulsions, 250 of maltodextrin are mixed with 50 mL of the micro and nanoemulsions. In this embodiment, 0.8 g of powdered micro and nanoemulsion ias is mixed with 100 g of a food, drink, food supplement or supplement, cosmetic product or medicine.
Ejemplo 6: Eliminar o suprimir el sabor y el olor de la emulsión Example 6: Eliminate or suppress the taste and odor of the emulsion
Al producto obtenido en el ejemplo 1 se añade una cantidad de 100 g de a- Ciclodextrina, para eliminar o suprimir el olor y el sabor de la emulsión, a los 0,8 g de la micro y nanoemulsión en polvo y se añaden a los 100 g de un alimento, bebida, complemento o suplemento alimenticios, producto de cosmética o medicamento. To the product obtained in Example 1, an amount of 100 g of a-Cyclodextrin is added, to eliminate or suppress the smell and taste of the emulsion, to the 0.8 g of the micro and nanoemulsion powder and they are added to the 100 g of a food, drink, food supplement or supplement, cosmetic product or medicine.

Claims

REIVINDICACIONES
1. Procedimiento de obtención de una micro y nanoemulsión de un tamaño menor de 55 pm del aceite de cáñamo que comprende cannabinoides, caracterizado por que comprende las siguientes etapas: 1. Procedure for obtaining a micro and nanoemulsion with a size smaller than 55 pm of hemp oil that comprises cannabinoids, characterized in that it comprises the following steps:
i. tratar un aceite de cáñamo que comprende cannabinoides, i. treat a hemp oil that contains cannabinoids,
con al menos una enzima lipasa que transforma los lípidos de mayor masa molecular a di- y monoglicéridos de ios ácidos grasos, ácidos grasos y glicerol, durante un tiempo de entre 1 minuto hasta 72 horas de tratamiento, y a una temperatura de entre 2 °C hasta 60 °C; with at least one lipase enzyme that transforms the lipids with the highest molecular mass into di- and monoglycerides of fatty acids, fatty acids and glycerol, for a time of between 1 minute and 72 hours of treatment, and at a temperature between 2 ° C up to 60 ° C;
o or
transesterificar mediante un tratamiento químico con KOH o NaOH desde el 0,5% hasta el 1% en peso como catalizadores, en donde la relación de alcohol / aceite es desde 3: 1 hasta 6: 1 ; transesterifying by chemical treatment with KOH or NaOH from 0.5% to 1% by weight as catalysts, where the alcohol / oil ratio is from 3: 1 to 6: 1;
ii. añadir al menos un antioxidante al producto obtenido en la etapa (i); y iii. aportar energía al producto obtenido en la etapa (ii), mediante un método seleccionado de entre agitación a una velocidad de agitación de entre 100 rpm hasta 30.000 rpm, donde el tiempo de actuación es de entre 10 segundos y 1 hora, o por ultrasonidos, a una potencia entre 20 y 3.000 watios y a una frecuencia entre 10 y 30 kHz durante un tiempo de sonicación de entre 5 segundos y 10 minutos. ii. adding at least one antioxidant to the product obtained in step (i); and iii. provide energy to the product obtained in stage (ii), by means of a method selected from stirring at a stirring speed of between 100 rpm and 30,000 rpm, where the action time is between 10 seconds and 1 hour, or by ultrasound, at a power between 20 and 3,000 watts and at a frequency between 10 and 30 kHz for a sonication time of between 5 seconds and 10 minutes.
2. El procedimiento según la reivindicación 1 , donde las enzimas de la etapa i) son lipasas, que producen lipolisis, de origen animal, microbiano o vegetal, desde 5 unidades de lipasa por gramo de aceite a 12.000 unidades de lipasa por gramo de aceite y están en una cantidad de entre 0,2 g hasta 100 g por cada 100 litros de aceite. 2. The process according to claim 1, wherein the enzymes of step i) are lipases, which produce lipolysis, of animal, microbial or plant origin, from 5 lipase units per gram of oil to 12,000 lipase units per gram of oil and they are in an amount of between 0.2 g to 100 g per 100 liters of oil.
3. El procecimento según la reivindicación 2 donde la enzima lipasa de la etapa (i) se combinan con proteasas, amilasas o celulasas para disminuir los pesos moleculares de las proteínas, polisacárldo y celulosa residuales a péptidos o aminoácidos y a monosacáridos. 3. The process according to claim 2 wherein the lipase enzyme of step (i) is combined with proteases, amylases or cellulases to decrease the molecular weights of the residual proteins, polysaccharide and cellulose to peptides or amino acids and to monosaccharides.
4. El procedimiento según cualquiera de las reivindicaciones 1 a 3, donde las enzimas de la etapa (i) se utilizan en formato inmovilizado. 4. The method according to any one of claims 1 to 3, wherein the enzymes of step (i) are used in immobilized format.
5. El procedimiento según cualquiera de las reivindicaciones 1 a 4, donde comprende añadir además al menos un surfactante en la etapa (i) en una cantidad de entre 1 % y 25% en peso con respecto a la cantidad aceite de cáñamo inicial. 5. The process according to any of claims 1 to 4, wherein it further comprises adding at least one surfactant in step (i) in an amount of between 1% and 25% by weight relative to the initial hemp oil amount.
6. El procedimiento según la reivindicación 1 , donde en la transesterificación de la etapa (i) se produce una metonolisis o etanolisís y se realiza enzimáíicamente con lipasas sin presencia de agua o en baja concentración. 6. The process according to claim 1, wherein in the transesterification of step (i) a metonolysis or ethanolysis occurs and is carried out enzymatically with lipases without the presence of water or in low concentration.
7. El procedimiento según cualquiera de las reivindicaciones 1 a 6, donde comprende una etapa adicionai (ii') de añadir al menos un surfactante tras la etapa (ii) y antes de la etapa (iii), donde dicho surfactante es seleccionado de entre surfactante natural fosfatídicos y surfactante de origen animal. 7. The process according to any of claims 1 to 6, wherein it comprises an additional step (ii ') of adding at least one surfactant after step (ii) and before step (iii), wherein said surfactant is selected from among natural phosphatidic surfactant and surfactant of animal origin.
8. El procedimiento según la reivindicación 7, donde si ios surfactantes de la etapa adicional (ii') se seleccionan de la lista que consiste en lecitina, fosfatidilserina, fosfatidilcolina, fosfatidiletanolamina, fosfatidilinositol, y ácido fosfatidico o sus combinaciones, adicionalmente se añaden en combinación con al menos: 8. The process according to claim 7, wherein if the surfactants of additional step (ii ') are selected from the list consisting of lecithin, phosphatidylserine, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, and phosphatidic acid or their combinations, they are additionally added in combination with at least:
- un surfactante no iónico, seleccionado de entre Tween 20, Tween 40, Tween 60, Tween 80, Tween 21 , Tween 85, Tween 65, Tween 81 , Tween 61 y Tween 100; - a non-ionic surfactant, selected from Tween 20, Tween 40, Tween 60, Tween 80, Tween 21, Tween 85, Tween 65, Tween 81, Tween 61 and Tween 100;
-un surfactante que se selecciona de la lista que consiste en Span 20, Span 40, Span 60, Span 65, y Span 85; - a surfactant that is selected from the list consisting of Span 20, Span 40, Span 60, Span 65, and Span 85;
-un sulfactante que se selecciona de la lista que consiste en almidones, caseinato de leche, leche en polvo, proteina de soja, proteina de guisante y proteína de suero; o - a sulfactant that is selected from the list consisting of starches, milk caseinate, milk powder, soy protein, pea protein and whey protein; or
-cualquiera de sus combinaciones; y -any of its combinations; Y
donde la relación en peso del total de surfactantes y aceite de cáñamo varía desde 10:1 hasta 1 :100. where the weight ratio of total surfactants and hemp oil ranges from 10: 1 to 1: 100.
9. El procedimiento según cualquiera de las reivindicaciones 7 u 8, donde comprende añadir al menos un eosurfactante, donde dicho eosurfacante se selecciona del grupo etanol, metanol, xilitol, sorbitol, glicerol, maititol o eritritol, o cualquiera de sus combinaciones. 9. The process according to any of claims 7 or 8, wherein it comprises adding at least one eosurfactant, wherein said eosurfactant is selected from the group ethanol, methanol, xylitol, sorbitol, glycerol, maititol or erythritol, or any of their combinations.
10. El procedimiento según cualquiera de las reivindicaciones 1 a 9, donde además comprende una etapa adicionai (iv) posterior a la etapa (iii), de añadir un agente secante, seleccionado de entre maltodextrinas, glucosa, lactosa, maititol, xilitol, eritritol, fructosa, metll celulosa, hidroxipropilmetilcelulosa, monofosfato, difosfato, trifosfato, polifosfato, cítrico, citratos, ascórbico, ascorbato, celulosa microcristalina, proteína de suero, proteína de leche, proteína de cáñamo, proteína de guisante, proteína de soja, leche en polvo o en sus combinaciones para que la emulsión esté en forma de polvo, en una relación en peso emulsificante/aceite de entre 4:1 a 7:1 , y posteriormente moler en molino de alta velocidad, molino de martillo, molino de rodillos, molino de disco, molino de bolas, mortero, o cualquier molino de alimentos con tipos de proceso fino o ultrafino. 10. The process according to any of claims 1 to 9, wherein it further comprises an additional step (iv) subsequent to step (iii), of adding an agent desiccant, selected from maltodextrins, glucose, lactose, maititol, xylitol, erythritol, fructose, methyl cellulose, hydroxypropyl methyl cellulose, monophosphate, diphosphate, triphosphate, polyphosphate, citric, citrates, ascorbic, ascorbate, whey protein, milk protein, cellulose , hemp protein, pea protein, soy protein, milk powder or their combinations so that the emulsion is in powder form, in an emulsifier / oil weight ratio of between 4: 1 to 7: 1, and subsequently grind in high speed mill, hammer mill, roller mill, disc mill, ball mill, mortar, or any food mill with fine or ultrafine process types.
11. El procecimento según la reivindicación 10, donde el secante es seleccionado de entre monofosfato, difosfato, trifosfato, polifosfato, cítrico, citratos, ascórbico, ascorbato. 11. The process according to claim 10, wherein the desiccant is selected from among monophosphate, diphosphate, triphosphate, polyphosphate, citric, citrates, ascorbic, ascorbate.
12. El procedimiento según cualquiera de las reivindicaciones 1 a 11 , donde además comprende una etapa adicional (v) 12. The process according to any of claims 1 to 11, wherein it further comprises an additional step (v)
* de dispersar el producto obtenido en la etapa (iii) o (iv) en una fase acuosa; o * of dispersing the product obtained in step (iii) or (iv) in an aqueous phase; or
• de absorber el producto obtenido en la etapa (iii) o (iv) en una fase sólida desde 5 mg en 100 mL hasta 10 g en 100 mL produciendo emulsiones transparentes. • to absorb the product obtained in stage (iii) or (iv) in a solid phase from 5 mg in 100 mL to 10 g in 100 mL, producing transparent emulsions.
13. El procedimiento según la reivindicación 12, donde además comprende añadir ai menos una ciclodextrina en una cantidad en porcentaje en peso de entre el 5% y el 400% con respecto al aceite de cáñamo inicial, seleccionado de entre a- Ciclodextrina, b-iclodextrina, y-Ciclodextrina, s- Ciclodextrina y derivados como 2- Hidroxípropii- b-iclodextrina, 2, Hydroxyethyl-b-iclodextrina, 2-Hidroxipropii-y- ciclodextrina, 2-Hidroxipropil-a-ciclodextrina, Metil-b-iclodextrina, Carboximetii-b- ciclodextrina sal sódica, 2-Carboxietil- b-iclodextrina sal sódica, Acetil-b- ciclodextrína, Succinil-b-iclodextrina, Succinil-a-ciclodextrina, Butil- b-iclodextrina o Butii-y-ciclodextrina y cualquier combinación de los anteriores, 13. The process according to claim 12, wherein it further comprises adding at least one cyclodextrin in an amount in percentage by weight of between 5% and 400% with respect to the initial hemp oil, selected from a- Cyclodextrin, b- iclodextrin, y-Cyclodextrin, s- Cyclodextrin and derivatives such as 2- Hydroxypropyl-b-iclodextrin, 2, Hydroxyethyl-b-iclodextrin, 2-Hydroxypropyl-y- cyclodextrin, 2-Hydroxypropyl-a-cyclodextrin, Methyl-b-iclodextrin Carboxymethii-b- cyclodextrin sodium salt, 2-Carboxyethyl-b-iclodextrin sodium salt, Acetyl-b-cyclodextrin, Succinyl-b-iclodextrin, Succinyl-a-cyclodextrin, Butyl-b-iclodextrin or Butii-y-cyclodextrin and any combination of the above,
- justo antes de la etapa (v); o - just before stage (v); or
al producto obtenido de la etapa (v); to the product obtained from step (v);
14. Una micro y nanoemulsión obtenida según el procedimiento descrito en cualquiera de las reivindiacaiones 1 a 13. 14. A micro and nanoemulsion obtained according to the process described in any one of claims 1 to 13.
15. Una micro y nanoemulsión caracterizada por que comprende 15. A micro and nanoemulsion characterized by comprising
• ai menos un cannabinoide en una cantidad en porcentaje en peso respecto a! total de la emulsión de entre 5% y 50%; • at least one cannabinoid in an amount in percentage by weight with respect to! total emulsion between 5% and 50%;
• monoglicéridos y diglicéridos; • monoglycerides and diglycerides;
• ácidos grasos; • fatty acids;
• glicerol; • glycerol;
• al menos un antioxidante; • at least one antioxidant;
• etii o metil ásteres de ios ácidos grasos o sus combinaciones; y • ethii or methyl esters of fatty acids or their combinations; Y
• opcionalmente al menos una enzima, preferiblemente una lipasa; • optionally at least one enzyme, preferably a lipase;
donde dichas micro y nanoemulsiones tienen un tamaño menor de 55 mm where said micro and nanoemulsions have a size smaller than 55 mm
18. Micro y nanoemulsión según la reivindicación 15, donde la enzima es una lipasa y se selecciona de entre lipasas de origen animal, microbiano o vegetal. 18. Micro and nanoemulsion according to claim 15, wherein the enzyme is a lipase and is selected from lipases of animal, microbial or plant origin.
17. Micro y nanoemulsión según cualquiera de las reivindicaciones 15 o 16, donde además comprende otras enzimas seleccionadas de entre proteasas, amilasas, celulasas y cualquier combinación de las anteriores. 17. Micro and nanoemulsion according to any of claims 15 or 16, wherein it also comprises other enzymes selected from proteases, amylases, cellulases and any combination of the foregoing.
18. Micro y nanoemulsión según cualquiera de las reivindicaciones 15 o 17, donde ei cannabinoide es cannabidiol. 18. Micro and nanoemulsion according to any of claims 15 or 17, wherein the cannabinoid is cannabidiol.
19. Micro y nanoemulsión según cualquiera de las reivindicaciones 15 a 18, donde además comprende ai menos un surfactante, preferiblemente seleccionado de entre surfactante natural fosfatidicos, surfactante de origen animal y cualquier combinación, y más preferiblemente surfactante natural fosfatidicos en combinación con un surfactante no iónico. 19. Micro and nanoemulsion according to any of claims 15 to 18, wherein it also comprises at least one surfactant, preferably selected from among natural phosphatidic surfactant, surfactant of animal origin and any combination, and more preferably natural phosphatidic surfactant in combination with a non-surfactant. ionic.
20. Micro y nanoemulsión según cualquiera de las reivindicaciones 15 a 19, donde además comprende al menos un cosurfactante, preferiblemente seleccionado de entre etanol, metanol, xilitol, sorbitol, glicerol, maltitol o eritritol, o en sus combinaciones. 20. Micro and nanoemulsion according to any of claims 15 to 19, wherein it also comprises at least one cosurfactant, preferably selected from ethanol, methanol, xylitol, sorbitol, glycerol, maltitol or erythritol, or in their combinations.
21. Micro y nanoemulsión según cualquiera de las reivindicaciones 15 a 20, donde ei antioxidante es seleccionado de entre tocoferoles, tocoferoles alfa, beta, gamma o delta, tocotrienoles, toeotrienoles alfa, beta, gamma o delta, astaxantina, fosfolípidos, ubiquinol, ubiquinona, glutatión, y sus combinaciones. 21. Micro and nanoemulsion according to any of claims 15 to 20, wherein the antioxidant is selected from among tocopherols, alpha, beta, gamma tocopherols or delta, tocotrienols, alpha, beta, gamma or delta toeotrieneols, astaxanthin, phospholipids, ubiquinol, ubiquinone, glutathione, and their combinations.
22. Micro y nanoemulsión según cualquiera de las reivindicaciones 15 a 21 , donde además comprende al menos un agente emulsificante, preferiblemente seleccionado de entre maltodextrina, glucosa, lactosa, maititol, xilitol, eritritol, fructosa, metil celulosa, hidroxipropilmetilcelulosa, celulosa microcristalina, proteína de suero, proteína de leche, proteína de cáñamo, proteína de guisante, proteína de soja, leche en polvo o en sus combinaciones. 22. Micro and nanoemulsion according to any of claims 15 to 21, where it also comprises at least one emulsifying agent, preferably selected from maltodextrin, glucose, lactose, maititol, xylitol, erythritol, fructose, methyl cellulose, hydroxypropylmethylcellulose, microcrystalline cellulose, protein whey, milk protein, hemp protein, pea protein, soy protein, milk powder or their combinations.
23. Micro y nanoemulsión según cualquiera de las reivindicaciones 15 a 22, donde además comprende al menos una ciclodextrina en una cantidad en porcentaje en peso de entre el 5% y el 400% con respecto al aceite de cáñamo inicial, seleccionado de entre a-Ciclodextrina, b-Ciclodextrina, y-Ciclodextrina, d- Ciclodextrina y derivados como 2-Hidroxipropil- b -ciclodextrina, 2, Hydroxyethyl-b- ciclodextrina, 2-Hidroxipropil-y-ciclodextrina, 2-Hidroxipropil-a-ciclodextrina, Metil-b- ciclodextrina, Carboximetil-b-ciclodextrina sal sódica, 2-Carboxietil-b-ciclodextrina sai sódica, Acetil-p-cidodextrina, Succinil-b-iclodextrina, Succinil-a-ciclodextrina, Butil- b -ciclodextrina o Butil-y-ciclodextrina y cualquier combinación de los anteriores. 23. Micro and nanoemulsion according to any of claims 15 to 22, wherein it also comprises at least one cyclodextrin in an amount in percentage by weight of between 5% and 400% with respect to the initial hemp oil, selected from a- Cyclodextrin, b-Cyclodextrin, y-Cyclodextrin, d- Cyclodextrin and derivatives such as 2-Hydroxypropyl- b-cyclodextrin, 2, Hydroxyethyl-b- cyclodextrin, 2-Hydroxypropyl-y-cyclodextrin, 2-Hydroxypropyl-a-cyclodextrin, Methyl b- cyclodextrin, Carboxymethyl-b-cyclodextrin sodium salt, 2-Carboxyethyl-b-cyclodextrin sodium salt, Acetyl-p-cidodextrin, Succinyl-b-iclodextrin, Succinyl-a-cyclodextrin, Butyl-b-cyclodextrin or Butyl-y- cyclodextrin and any combination of the above.
24. Micro y nanoemulsión según cualquiera de las reivindicaciones 15 a 23, donde el monoglicérído y diglicérido, ios ácidos grasos y el glicerol, son producto de la reacción del aceite de cáñamo con enzimas. 24. Micro and nanoemulsion according to any of claims 15 to 23, wherein the monoglyceride and diglyceride, fatty acids and glycerol, are the product of the reaction of hemp oil with enzymes.
25. Una composición que comprende la micro y nanoemulsión según cualquiera de las reivindicaciones 15 a 24. 25. A composition comprising the micro and nanoemulsion according to any of claims 15 to 24.
26. La composición según la reivindicación 25, donde la composición es un alimento, una bebida, un complemento o suplemento alimenticio, una composción cosmética o una composición farmacéutica. 26. The composition according to claim 25, wherein the composition is a food, a beverage, a food supplement or supplement, a cosmetic composition or a pharmaceutical composition.
27. La composicón según la reivindicación 26, donde la bebida se selecciona del grupo que consiste en bebida energética, agua potable o mineral, limonada, agua tónica, agua de fruta, jugo de fruta, leche, suero de leche, bebida gaseosa y bebida alcohólica. 27. The composition according to claim 26, wherein the drink is selected from the group consisting of energy drink, drinking or mineral water, lemonade, tonic water, fruit water, fruit juice, milk, buttermilk, soda and alcoholic beverage.
PCT/ES2019/070769 2019-05-10 2019-11-11 Micro- and nanoemulsions of hemp oil cannabinoids WO2020229711A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201900242U ES1245259Y (en) 2019-05-10 2019-05-10 Hemp oil cannabinoid emulsions
ESU201900242 2019-05-10

Publications (1)

Publication Number Publication Date
WO2020229711A1 true WO2020229711A1 (en) 2020-11-19

Family

ID=70294290

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2019/070769 WO2020229711A1 (en) 2019-05-10 2019-11-11 Micro- and nanoemulsions of hemp oil cannabinoids

Country Status (2)

Country Link
ES (1) ES1245259Y (en)
WO (1) WO2020229711A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022226639A1 (en) * 2021-04-26 2022-11-03 Hexo Operations Inc. Water-soluble cannabis cannabinoid systems for infusing products with nanoemulsions having nanoscale sizes
WO2023235740A3 (en) * 2022-06-01 2024-01-25 University Of Vermont And State Agricultural College Compositions comprising hemp extract, consumables comprising hemp extract, and methods of mitigating hemp flavor thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0237092A1 (en) * 1986-03-10 1987-09-16 Berol Kemi Ab Transesterification process
US6337414B1 (en) 1998-07-09 2002-01-08 Kao Corporation Process for producing partial glyceride
US7118688B2 (en) 2004-02-23 2006-10-10 The Texas A&M University System Antioxidant compositions and methods of use thereof
JP2012019801A (en) * 2011-11-01 2012-02-02 Japan Tobacco Inc Method for manufacturing oil-in-water type emulsion
US9775907B2 (en) 2012-07-30 2017-10-03 Matinas Biopharma Nanotechnologies, Inc. Cochleates made with soy phosphatidylserine
US9907823B1 (en) 2014-11-07 2018-03-06 Eric H. Kuhrts Water-soluble phytocannabinoid formulations
WO2019025880A1 (en) * 2017-08-04 2019-02-07 Alsec Alimentos Secos S.A.S. Cannabis oil nanoparticles micro-encapsulated in powder

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0237092A1 (en) * 1986-03-10 1987-09-16 Berol Kemi Ab Transesterification process
US6337414B1 (en) 1998-07-09 2002-01-08 Kao Corporation Process for producing partial glyceride
US7118688B2 (en) 2004-02-23 2006-10-10 The Texas A&M University System Antioxidant compositions and methods of use thereof
JP2012019801A (en) * 2011-11-01 2012-02-02 Japan Tobacco Inc Method for manufacturing oil-in-water type emulsion
US9775907B2 (en) 2012-07-30 2017-10-03 Matinas Biopharma Nanotechnologies, Inc. Cochleates made with soy phosphatidylserine
US9907823B1 (en) 2014-11-07 2018-03-06 Eric H. Kuhrts Water-soluble phytocannabinoid formulations
WO2019025880A1 (en) * 2017-08-04 2019-02-07 Alsec Alimentos Secos S.A.S. Cannabis oil nanoparticles micro-encapsulated in powder

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DAVID JULIAN MCCLEMENTS: "Nanoemulsions versus microemulsions: terminology, differences, and similarities", SOFT MATTER, vol. 8, no. 6, 1 January 2012 (2012-01-01), pages 1719 - 1729, XP055679405, ISSN: 1744-683X, DOI: 10.1039/C2SM06903B *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022226639A1 (en) * 2021-04-26 2022-11-03 Hexo Operations Inc. Water-soluble cannabis cannabinoid systems for infusing products with nanoemulsions having nanoscale sizes
WO2023235740A3 (en) * 2022-06-01 2024-01-25 University Of Vermont And State Agricultural College Compositions comprising hemp extract, consumables comprising hemp extract, and methods of mitigating hemp flavor thereof

Also Published As

Publication number Publication date
ES1245259U (en) 2020-04-27
ES1245259Y (en) 2020-08-24

Similar Documents

Publication Publication Date Title
Dammak et al. Nanoemulsions: Using emulsifiers from natural sources replacing synthetic ones—A review
Chen et al. Phytosterol structured algae oil nanoemulsions and powders: Improving antioxidant and flavor properties
CN100475193C (en) Nano-sized self-assembled structured liquid
Li et al. Nanoemulsion-based delivery approaches for nutraceuticals: Fabrication, application, characterization, biological fate, potential toxicity and future trends
US5968549A (en) Solubilisation aids
Cheong et al. In-vitro gastrointestinal digestion of kenaf seed oil-in-water nanoemulsions
ES2459217T3 (en) Enzymatic production of hydrolyzed lecithin products
JP2006075164A (en) Emulsion containing unsaturated fatty acid and its ester
CN107080734A (en) The emulsion of PEG derivatives comprising tocopherol
CN103037708A (en) Nanoemulsion including sucrose fatty acid ester
AU2008201045A1 (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
Costa et al. The antioxidant activity of nanoemulsions based on lipids and peptides from Spirulina sp. LEB18
WO2020229711A1 (en) Micro- and nanoemulsions of hemp oil cannabinoids
KR20200034789A (en) Oil-in-water emulsion composition and food and beverage containing the same
US9427404B2 (en) Microemulsion preconcentrates and microemulsions, and preparation processes of the same
Chatzidaki et al. Water-in-oil microemulsions versus emulsions as carriers of hydroxytyrosol: An in vitro gastrointestinal lipolysis study using the pHstat technique
JP2019115370A (en) Powder composition, method for producing same, and beverage
Cheng et al. Effect of different structural flaxseed lignans on the stability of flaxseed oil-in-water emulsion: An interfacial perspective
MXPA05005720A (en) Emulsive water-soluble concentrates.
TW200848513A (en) Lipase powder preparation, method of preparing the same and use thereof
Rossi Use of lecithin and lecithin fractions
CN111492044B (en) Method for preparing monoglyceride oil and food product containing monoglyceride oil
Guo et al. A notable impact of lipid matrices on cholesterol bioaccessibility from phytosterols-loaded nanostructured lipid carriers during in vitro intestinal digestion
Karthik et al. Natural compound-based interfacial stabilization of nanoemulsions
JP2015027260A (en) Producing method of phosphatidylinositol and composition comprising phosphatidylinositol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19836811

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19836811

Country of ref document: EP

Kind code of ref document: A1